syndrome	score	normalized_score
DRAVET SYNDROME	2.6655186999999994	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	1.3805416	51.792606069505354
DOORS SYNDROME	1.3486830539999999	50.597396071541354
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	1.27307696	47.76094649045232
MYOCLONIC-ASTASTIC EPILEPSY	1.220921494	45.804274192486446
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.222966696875936
LYMPHATIC MALFORMATION 1	1.0416667	39.07932441066724
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0333333	38.76668732430954
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.008117179	37.82067554056178
RETT SYNDROME; RTT	1.007958999	37.8147412359178
GABRIELE-DE VRIES SYNDROME	1.0048951	37.69979554073285
COFFIN-SIRIS SYNDROME 2; CSS2	1.0020485110000001	37.59300248015519
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.53646219026714
ANONYCHIA WITH FLEXURAL PIGMENTATION	1.0	37.51615023372375
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	1.0	37.51615023372375
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372375
CURVED NAIL OF FOURTH TOE	1.0	37.51615023372375
MYOCLONIC EPILEPSY OF LAFORA	0.95944076	35.994523692518094
SEMANTIC DEMENTIA	0.920833	34.54610916817054
PROGRESSIVE NON-FLUENT APHASIA	0.9129429	34.25010299121144
LAFORA DISEASE	0.7732153	29.00806135781378
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627652
CRANIOSYNOSTOSIS 4; CRS4	0.75	28.137112675292812
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.08380087522928
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607875
POSTERIOR CORTICAL ATROPHY	0.6989939999999999	26.22356391647149
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6974366739999999	26.165139040292612
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309247
ROLANDIC EPILEPSY	0.5906213	22.157837422037225
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5849288	21.944276736831753
INHALATIONAL ANTHRAX	0.5833333	21.88441971913385
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.5357143	20.097938161154154
CITRULLINEMIA TYPE II	0.5344202730000001	20.049391249815663
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228727
SMITH-FINEMAN-MYERS SYNDROME	0.521374719	19.559972286069506
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.5197757940000001	19.499986775557048
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517808602	19.42618530494647
HYPODONTIA-DYSPLASIA OF NAILS SYNDROME	0.516129	19.363173103981605
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.510220798	19.141520110138416
TEMPLE-BARAITSER SYNDROME	0.5085708870000001	19.079621801190147
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845318
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.505803324	18.975793491900852
CORTICOBASAL SYNDROME	0.504167	18.9144049148858
TEMPLE-BARAITSER SYNDROME; TMBTS	0.502048511	18.83492736329331
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.501507092	18.81461540674992
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.77838707340527
CREST SYNDROME	0.5	18.758075116861875
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	18.758075116861875
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861875
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.5	18.758075116861875
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.758075116861875
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.5	18.758075116861875
49,XYYYY SYNDROME	0.5	18.758075116861875
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861875
PAROXYSMAL HEMICRANIA	0.5	18.758075116861875
SPINOCEREBELLAR ATAXIA TYPE 10	0.474039178	17.784125018518914
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.4350356	16.320860926618153
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.42617084000000005	15.988289258672248
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42242719000000006	15.84784192284977
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41897745399999997	15.718421108807078
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.40998736	15.381147391687783
PERIORAL MYOCLONIA WITH ABSENCES	0.40159691	15.066370008959234
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39648946	14.874758147448002
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.392697919	14.732514125674681
CHILDHOOD APRAXIA OF SPEECH	0.3830966	14.372309599628775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.381871992	14.326367021923353
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769368
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769368
CENTRALOPATHIC EPILEPSY	0.3547009	13.307012252437023
HYPERTRICHOSIS CUBITI	0.350988754	13.167746825411509
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348537004	13.075766604075975
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346334392	12.993133081377373
OROFACIODIGITAL SYNDROME TYPE 3	0.3462259	12.989062879206214
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.345788838	12.972665995552763
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.34120729000000005	12.800783952481748
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34037525	12.76956901484128
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.76956901484128
COG4-CDG	0.337375054	12.657013210974663
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.33717915	12.649663647079274
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.335560759	12.588947847186368
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.33501934	12.568635890642977
OCULOPHARYNGODISTAL MYOPATHY	0.333333	12.505370905857838
BIFID UVULA	0.333333	12.505370905857838
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.505370905857838
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857838
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857838
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.32860944000000003	12.328161119259832
DYSTONIA 6, TORSION	0.31923024	11.97628964298769
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31566591	11.84256970322512
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30224295199999995	11.338991994316155
WRINKLY SKIN SYNDROME	0.302194754	11.337183790907192
WEST SYNDROME	0.2822581	10.58923728428542
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.2819444	10.577468467957102
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.280216797	10.512655454264872
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.27668634000000003	10.38020629905917
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.27639383399999995	10.369232600018902
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.27255881000000004	10.22535726348497
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.25916504	9.722874575969024
CONGENITAL ENTEROVIRUS INFECTION	0.25840336	9.694299274659004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.590251758503891
PALLISTER-HALL SYNDROME	0.254819054	9.559829912279366
HYPEREKPLEXIA 1; HKPX1	0.2542735	9.539362826454756
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.251502957	9.435422719037765
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.250545554	9.399504644255547
SPEECH-LANGUAGE DISORDER 1	0.2500003	9.379048813276007
HYPERPARATHYROIDISM 2	0.25	9.379037558430937
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430937
OROFACIODIGITAL SYNDROME TYPE 10	0.25	9.379037558430937
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.246258732	9.238679586078314
KUFOR-RAKEB SYNDROME	0.24527644	9.20182777183293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042525
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.241495038	9.059964126306825
UNILATERAL POLYMICROGYRIA	0.2346684	8.803854949507578
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.801844233919653
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013938
INFANTILE MYOFIBROMATOSIS	0.23225810000000002	8.713429772599234
BILATERAL POLYMICROGYRIA	0.23154956399999999	8.686848229577231
LÉRI-WEILL DYSCHONDROSTEOSIS	0.2261903	8.485789276211046
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577507
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.22388017100000002	8.399122129587763
HAND-FOOT-GENITAL SYNDROME	0.21960780000000002	8.23883921729756
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21853340400000001	8.198532015551047
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21834761000000003	8.191561739934523
COFFIN-SIRIS SYNDROME	0.213135173	7.9960111703587025
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.8184917629728155
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.208271014	7.813526650553983
COFFIN-SIRIS SYNDROME 7; CSS7	0.20647712199999999	7.7462267287789075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.2013986	7.555700134461636
6P22 MICRODELETION SYNDROME	0.2013986	7.555700134461636
HYPERTRYPTOPHANEMIA; HYPTRP	0.20054555400000001	7.523697132569359
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.20054555400000001	7.523697132569359
SPASTIC PARAPLEGIA 16, X-LINKED	0.2	7.503230046744751
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744751
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.2	7.503230046744751
BETA-THALASSEMIA	0.2	7.503230046744751
STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	0.2	7.503230046744751
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744751
JUVENILE HYALINE FIBROMATOSIS	0.2	7.503230046744751
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.198837054	7.459600789895042
FILIPPI SYNDROME	0.196911673	7.3873679070418845
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.194990354	7.315287414790977
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.19438934400000002	7.292739833339007
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.18962994	7.11418531785202
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.1052493460278505
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.18913359999999999	7.0955645518450146
9P13 MICRODELETION SYNDROME	0.18846810000000003	7.070597553864472
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.18843271	7.0692698573077
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.18717955399999997	7.022256268545406
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.18481994999999998	6.933733010389311
DDOST-CDG	0.18413454699999998	6.908019328470666
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
MYOCLONIC EPILEPSY OF INFANCY	0.182972154	6.864410818052037
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.182972154	6.864410818052037
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.17835560899999997	6.691215822271291
8Q21.11 MICRODELETION SYNDROME	0.17749956	6.6591001593798635
FREEMAN-SHELDON SYNDROME	0.17521401	6.573355122213176
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	6.569644399793556
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130534
ADULT-ONSET DYSTONIA-PARKINSONISM	0.169440313	6.356748238157175
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.169137192	6.345376305182178
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.16835334000000002	6.315969195789174
AGEL AMYLOIDOSIS	0.16835334000000002	6.315969195789174
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.16835334000000002	6.315969195789174
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16765261399999998	6.289680653900496
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.16742994	6.281326782663353
VERRUCOUS HEMANGIOMA	0.166667	6.252704211004037
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.166667	6.252704211004037
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.166667	6.252704211004037
CUTANEOUS NEUROENDOCRINE CARCINOMA	0.166667	6.252704211004037
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.166667	6.252704211004037
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.166667	6.252704211004037
FETAL AKINESIA DEFORMATION SEQUENCE	0.166667	6.252704211004037
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16042104	6.018379837290206
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.1583333	5.940055869801252
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15800176	5.927617765352763
FREE SIALIC ACID STORAGE DISEASE	0.15712461299999997	5.894710586723702
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15711985199999998	5.89453197233244
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15585839199999998	5.8472068494586065
DISTAL MONOSOMY 7Q36	0.15544661899999998	5.8317587117284155
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.727283548976791
FOCAL DERMAL HYPOPLASIA	0.15039125	5.642100728837507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14534914799999998	5.452940472711747
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.144160752	5.408356429838592
COMBINED SAPOSIN DEFICIENCY	0.143818538	5.395517878002508
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14339841899999997	5.379756630482465
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.379756630482465
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.143157951	5.370735196868063
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.359444673939073
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.359444673939073
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.359444673939073
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.14285699999999998	5.359444673939073
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.359444673939073
PACMAN DYSPLASIA	0.14285699999999998	5.359444673939073
GLOMUVENOUS MALFORMATION	0.14285699999999998	5.359444673939073
PIEBALDISM	0.14285699999999998	5.359444673939073
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.14241024	5.342683958660655
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.14215457099999998	5.333092242046549
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.14172600000000002	5.317013908024733
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.141239338	5.298756223319687
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422205
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.1306721	4.902314134956173
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.13061906699999998	4.900324540960828
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.130128238	4.88191052645776
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.12965840299999998	4.864284126012698
CHARGE SYNDROME	0.12927349999999999	4.849844047239286
WILLIAMS SYNDROME	0.12915812	4.8455154338253195
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.12857143	4.823505083644696
MICROPHTHALMIA, SYNDROMIC 1	0.127901557	4.7983740275391815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.126944154	4.762455952756964
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.126944154	4.762455952756964
ACROOTOOCULAR SYNDROME	0.1263986	4.741988866932354
MONOSOMY 18Q	0.126086973	4.73029782158347
DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	0.125	4.689518779215469
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.125	4.689518779215469
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.125	4.689518779215469
SPINOCEREBELLAR ATAXIA TYPE 40	0.12300984	4.614855637666321
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.121877352	4.572369047720431
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.12024401400000001	4.511092493929982
PITT-HOPKINS SYNDROME	0.12002001300000002	4.502688838761478
COOKS SYNDROME	0.11904760000000002	4.466207646564252
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.1166667	4.376885444472778
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.1166667	4.376885444472778
AUTOIMMUNE HYPOPARATHYROIDISM	0.1166667	4.376885444472778
AICARDI SYNDROME; AIC	0.115759338	4.342844715364406
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.11317881900000001	4.246033576879428
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.242900265528058
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.11263740000000001	4.225721620336036
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.11121805399999998	4.1724732225664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	4.005181580605681
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.10654991900000002	3.9973427685950975
VELOCARDIOFACIAL SYNDROME	0.105235	3.9480120698459187
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.10521451400000001	3.947243513992231
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.10428935	3.9125349223773984
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.10416660000000001	3.907929814936209
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.10238735400000001	3.841179354697457
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.10218487799999999	3.8335832346627323
17P11.2 MICRODUPLICATION SYNDROME	0.10191134399999999	3.8233212920247004
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.101685164	3.8148358891648373
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.101530173	3.8090212235239624
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.101530173	3.8090212235239624
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.10108985000000001	3.7925019997045992
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.10098875400000001	3.788709266980571
MIETENS SYNDROME	0.10098875400000001	3.788709266980571
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.1004902	3.7700054402169463
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.1004902	3.7700054402169463
MILROY DISEASE	0.1004902	3.7700054402169463
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.10044320000000001	3.768242181155962
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.10044320000000001	3.768242181155962
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.10044320000000001	3.768242181155962
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.099535719	3.7341969876257113
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.7123395157572903
DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA, NAILS ONLY	0.0982143	3.6846224339000146
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6811540658109063
DYSTONIA-APHONIA SYNDROME	0.09724031300000001	3.648082191282321
ANONYCHIA-MICROCEPHALY SYNDROME	0.09538150000000001	3.5783466835179225
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.09517872799999999	3.5707394587027292
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.094990054	3.563661136573532
RING CHROMOSOME 7 SYNDROME	0.09310205999999999	3.492830870029162
ADAMS-OLIVER SYNDROME	0.09227807900000001	3.4619182750434287
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.092208119	3.4592936451730774
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0921099	3.455608846413271
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.091815454	3.444562366041552
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09151624399999998	3.4333371587301187
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.090023292	3.3773273472063816
LANDAU-KLEFFNER SYNDROME	0.08858697299999999	3.3234421878188285
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.088045554	3.303130231275437
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.087252231	3.2733678064235687
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0870714	3.266583723460654
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.086004359	3.226552452999111
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.085580679	3.210657610468087
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08545307	3.205870212052912
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.08527745400000002	3.1992817758134664
2Q32Q33 MICRODELETION SYNDROME	0.08527745400000002	3.1992817758134664
FRIEDREICH ATAXIA	0.08501964000000001	3.1896095870571095
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.08484045200000001	3.182887143129029
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.08473190000000001	3.1788146899888576
DYSKERATOSIS CONGENITA	0.08387885400000002	3.146811688096581
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.083858122	3.1460339032699345
X-LINKED ADRENOLEUKODYSTROPHY	0.0838235	3.1447350191165424
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.083484633	3.132022033835292
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.08333330000000001	3.1263446022719714
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.08333330000000001	3.1263446022719714
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.08333330000000001	3.1263446022719714
KEIPERT SYNDROME	0.08333330000000001	3.1263446022719714
SALT-AND-PEPPER SYNDROME	0.082363642	3.0899667670686393
CENANI-LENZ SYNDROME	0.08210780000000001	3.0803685601605433
PHELAN-MCDERMID SYNDROME	0.080847161	3.0330742380460514
KUFOR-RAKEB SYNDROME	0.079150859	2.9694355173722857
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.078629	2.9498573767274645
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.07860944	2.9491235608288933
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.07860944	2.9491235608288933
DERMOODONTODYSPLASIA	0.07843130000000001	2.942440433826258
DUBOWITZ SYNDROME	0.07814024800000001	2.9315212832684323
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07813835999999999	2.93145045277679
TUBEROUS SCLEROSIS COMPLEX	0.07794046	2.9240260066455366
ATYPICAL JUVENILE PARKINSONISM	0.07746451900000001	2.906170532587148
SCHINZEL-GIEDION SYNDROME	0.07710070000000001	2.892521444325265
LOCKED-IN SYNDROME	0.07692310000000001	2.8858585760437556
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437556
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437556
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07677007100000001	2.8801175170896394
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.862823659800249
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07571526	2.8405450691454543
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.07568064	2.8392462600243626
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07527475000000002	2.8240188298059974
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0749525	2.8119292503931796
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0749525	2.8119292503931796
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07427589999999999	2.7865458231450413
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.07417580000000001	2.7827904565066466
CHROMOSOME 16P13.2 DELETION SYNDROME	0.073610311	2.761575486227128
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0732084	2.746497332770542
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.07309865700000001	2.7423801978954425
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.073061059	2.740969665678955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07293569200000001	2.7362663784726036
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07293569200000001	2.7362663784726036
JUVENILE PRIMARY LATERAL SCLEROSIS	0.0727513	2.729348700498707
PRIMARY LATERAL SCLEROSIS	0.0727513	2.729348700498707
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.07254992900000001	2.721794035809992
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.07230196	2.712491193552685
ACROMEGALY	0.0715198	2.6831475614858755
SOMATOMAMMOTROPINOMA	0.0715198	2.6831475614858755
TRICHOTHIODYSTROPHY	0.071481792	2.6817216476477923
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845606
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.071098494	2.6673417822955066
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.070708754	2.652720237903415
TONNE-KALSCHEUER SYNDROME; TOKAS	0.070417352	2.641787956693008
OROFACIODIGITAL SYNDROME TYPE 2	0.070087804	2.6294245844157844
DYSTONIA 16; DYT16	0.06923024	2.597252084556751
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06879887900000001	2.5810690804757823
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.577123169310349
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.068606719	2.5738599770468693
LYNCH SYNDROME	0.068299189	2.562322635365492
FAMILIAL COLORECTAL CANCER TYPE X	0.068299189	2.562322635365492
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.068173792	2.557618222674634
FOCAL DERMAL HYPOPLASIA; FDH	0.0681721	2.557554745348439
SMITH-MAGENIS SYNDROME; SMS	0.068119941	2.555597940468398
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.067628238	2.5371511368500252
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.067208119	2.5213898893299835
SECONDARY SYRINGOMYELIA	0.067208119	2.5213898893299835
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.067208119	2.5213898893299835
ISOLATED CLEFT LIP	0.0667735	2.505084657631553
SPINOCEREBELLAR ATAXIA TYPE 35	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.066537919	2.496246565443342
PELIZAEUS-MERZBACHER DISEASE	0.066234851	2.484876620824308
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.06607143	2.478745694036962
RHEUMATIC FEVER	0.06607143	2.478745694036962
WHITE-SUTTON SYNDROME; WHSUS	0.065878872	2.471521659180257
CHRISTIANSON SYNDROME	0.06565625	2.463169738782925
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.065405692	2.4537697672126635
RING CHROMOSOME 12 SYNDROME	0.065396334	2.4534186910787765
SPINOCEREBELLAR ATAXIA 1	0.06514787799999999	2.444097578456306
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.431601774168758
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.431601774168758
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.064727759	2.428336330936264
CHOREOACANTHOCYTOSIS	0.064727759	2.428336330936264
ACERULOPLASMINEMIA	0.06418634	2.408024374392872
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.06418634	2.408024374392872
SPINOCEREBELLAR ATAXIA TYPE 21	0.06418634	2.408024374392872
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.06418634	2.408024374392872
SPINOCEREBELLAR ATAXIA 15	0.06418634	2.408024374392872
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.06418634	2.408024374392872
SPINOCEREBELLAR ATAXIA TYPE 27	0.06418634	2.408024374392872
KEIPERT SYNDROME; KPTS	0.0638986	2.3972294773246206
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.06372334	2.390654396834658
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.063586973	2.385538431975736
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.06351011000000001	2.3826548281203213
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.063484719	2.3817022555497362
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.063461538	2.3808325936711685
ADDUCTED THUMBS SYNDROME	0.063461538	2.3808325936711685
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.063461538	2.3808325936711685
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.063045554	2.365226475432343
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.063045554	2.365226475432343
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.063045554	2.365226475432343
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.062865554	2.358473568390273
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0625	2.3447593896077343
%614927 ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5	0.0625	2.3447593896077343
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0625	2.3447593896077343
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.0625	2.3447593896077343
BOUCHER-NEUHAUSER SYNDROME	0.0625	2.3447593896077343
SPINOCEREBELLAR ATAXIA TYPE 37	0.0625	2.3447593896077343
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.0625	2.3447593896077343
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0625	2.3447593896077343
NEUROFIBROMATOSIS TYPE 2	0.0625	2.3447593896077343
PALATOPHARYNGEAL INCOMPETENCE	0.0625	2.3447593896077343
CLEFT VELUM	0.0625	2.3447593896077343
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.0625	2.3447593896077343
CLEFT LIP/PALATE	0.0625	2.3447593896077343
MIYOSHI MYOPATHY	0.0625	2.3447593896077343
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.0625	2.3447593896077343
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0625	2.3447593896077343
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.0625	2.3447593896077343
%614149 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9;;ANONYCHIA-ONYCHOLYSIS, ISOLATED;;ONYCHODYSTROPHY;;NAIL DYSPLASIA	0.0625	2.3447593896077343
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.061615714	2.3115843831821556
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.061051259000000004	2.290408204601979
RING CHROMOSOME 22 SYNDROME	0.060872011	2.2836835097048844
ADNP SYNDROME	0.06071181899999999	2.277673722566644
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0602221	2.2593013509903352
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0602221	2.2593013509903352
POTOCKI-LUPSKI SYNDROME	0.060061261000000005	2.253267290902893
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.059464249999999996	2.2308697365357073
NOCARDIOSIS	0.059364919	2.2271432198168415
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
GITELMAN SYNDROME	0.059127030000000004	2.218218540353891
ADULT SYNDROME	0.0588235	2.206831263273449
HUNTINGTON DISEASE-LIKE 2	0.0588235	2.206831263273449
YELLOW NAIL SYNDROME	0.0588235	2.206831263273449
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	2.206831263273449
BUTYRYLCHOLINESTERASE	0.0588235	2.206831263273449
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	2.206831263273449
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.0583136	2.187701778269273
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.05753969999999999	2.158668029603394
ZLOTOGORA-OGUR SYNDROME	0.05685092900000001	2.1328279932907623
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0566448	2.125094826759235
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.0566448	2.125094826759235
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.1203054399880976
COFFIN-SIRIS SYNDROME 5	0.056426773	2.116915293072227
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.056387983999999995	2.115460079120811
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.05593431299999999	2.0984400897281272
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.055739252	2.091122151947387
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246634
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246634
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246634
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246634
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246634
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246634
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246634
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0842322359246634
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.055125952	2.068113497009044
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.054686993999999996	2.0516454827347492
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0533507	2.001512876274326
ERYTHERMALGIA, PRIMARY	0.05307093	1.9910169829234368
DISTAL MONOSOMY 10Q	0.052498252999999995	1.9695323465560381
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.05245646099999999	1.9679644716054705
CRONKHITE-CANADA SYNDROME	0.052384719	1.9652729879554032
DYSTONIA 28, CHILDHOOD-ONSET	0.052231894	1.959539582295934
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.052181741	1.957658034813262
DISTAL MONOSOMY 12Q	0.052148151999999996	1.9563979048430615
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.05188749799999999	1.9466191702200404
KID SYNDROME	0.0518433	1.9449610314120105
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.05181181099999999	1.9437796853573004
SPINOCEREBELLAR ATAXIA TYPE 20	0.051686340000000004	1.9390724964713253
DYSTONIA 26, MYOCLONIC; DYT26	0.051686340000000004	1.9390724964713253
PRIMARY DYSTONIA, DYT6 TYPE	0.051686340000000004	1.9390724964713253
OROMANDIBULAR DYSTONIA	0.051686340000000004	1.9390724964713253
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.920118549534093
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.05110065999999999	1.9171000376024376
SARCOSINEMIA	0.051035064	1.9146391282117063
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.05088663	1.909070455967914
AICARDI SYNDROME	0.05020198	1.883385023710395
AICARDI-GOUTIÈRES SYNDROME	0.050048873	1.87764103849656
PRIMARY DYSTONIA, DYT21 TYPE	0.05	1.8758075116861876
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.05	1.8758075116861876
PRIMARY DYSTONIA, DYT27 TYPE	0.05	1.8758075116861876
PRIMARY DYSTONIA, DYT4 TYPE	0.05	1.8758075116861876
DYSTONIA 21; DYT21	0.05	1.8758075116861876
DYSTONIA 27; DYT27	0.05	1.8758075116861876
DYSTONIA 25	0.05	1.8758075116861876
BOHRING-OPITZ SYNDROME	0.049906141	1.8722862833414005
WEAVER SYNDROME	0.04967505099999999	1.863616676183889
TRISOMY 18	0.049630754	1.8619548232769858
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.049076854	1.8411746276625265
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8411746276625265
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.048613804	1.8238027742968004
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.821769624051034
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0485313	1.8207075418379175
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.04796294	1.7993848626910784
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.047777454	1.7924261420488257
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.784391908411673
HALLERMANN-STREIFF SYNDROME; HSS	0.04690235	1.7595956089146931
8Q24.3 MICRODELETION SYNDROME	0.046803721000000006	1.7558954285332915
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.046580329999999996	1.7475146582164294
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.046549349999999996	1.7463524078821884
RETT SYNDROME	0.046374719	1.7398009250507231
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.046276898	1.7361310577187101
CRI-DU-CHAT SYNDROME	0.04615381	1.7315132698187419
LYMPHEDEMA, HEREDITARY, III	0.04605840399999999	1.7279340039895423
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.046054268999999995	1.7277788747083263
TRISOMY 8P	0.045983447000000004	1.7251219059164737
AU-KLINE SYNDROME; AUKS	0.045971582000000004	1.7246767767939506
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.045687922000000006	1.7140349456186526
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.045238129999999994	1.697160481372725
HEREDITARY ACROKERATOTIC POIKILODERMA	0.04514826	1.6937889049512207
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.04514826	1.6937889049512207
CARDIOFACIOCUTANEOUS SYNDROME	0.045118054000000005	1.6926556921172609
TARP SYNDROME; TARPS	0.044964252	1.6868856331790134
FONTAINE PROGEROID SYNDROME; FPS	0.044962588	1.6868232063050246
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
COSTELLO SYNDROME; CSTLO	0.044830314	1.6818607950490092
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.044775794	1.6798154145382664
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0445451	1.6711606637762475
GALACTOSEMIA	0.044440012999999993	1.6672182040966363
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.044228302	1.6592756224145042
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.044210292	1.6585999565487952
ALEXANDER DISEASE	0.044176389	1.6573280465074214
MENTAL RETARDATION, X-LINKED 98; MRX98	0.044108583	1.6547842264246733
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.043715211	1.640026423374933
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.04371521099999999	1.6400264233749327
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.04371521099999999	1.6400264233749327
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04336706	1.6269651381549117
CLASSIC GALACTOSEMIA	0.043353039999999995	1.626439161728635
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.043211533	1.6211303638575116
CHROMOSOME 1P36 DELETION SYNDROME	0.043122791	1.6178011056534702
16P13.11 MICRODELETION SYNDROME	0.042827304	1.6067155709693577
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04279685	1.60557305413014
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.04275367299999999	1.6039532193114985
MICROTRIPLICATION 11Q24.1	0.04262823799999999	1.5992473810069314
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.04230765	1.5872201534358026
COG2-CDG	0.04221225399999999	1.5836412627681058
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.04221225399999999	1.5836412627681058
COWDEN SYNDROME 5; CWS5	0.042208118999999995	1.5834861334868895
COWDEN SYNDROME 6; CWS6	0.042208118999999995	1.5834861334868895
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.5765019393786286
TRANSIENT NEONATAL DIABETES MELLITUS	0.041847064	1.5699407398642526
PERMANENT NEONATAL DIABETES MELLITUS	0.041847064	1.5699407398642526
THROMBOCYTOPENIA 1	0.041692059999999996	1.5641255865134245
PEROXISOME BIOGENESIS DISORDER 14B	0.041666699999999994	1.5631741769434973
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.041666699999999994	1.5631741769434973
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.041666699999999994	1.5631741769434973
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.041666699999999994	1.5631741769434973
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.041666699999999994	1.5631741769434973
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.041666699999999994	1.5631741769434973
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.041666699999999994	1.5631741769434973
INCONTINENTIA PIGMENTI	0.041074773	1.5409673546841
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.040830533	1.5318044101510153
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.04080511	1.5308506370636232
NIEMANN-PICK DISEASE, TYPE C2	0.040771851000000005	1.529602887423
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.040771851000000005	1.529602887423
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.040771851000000005	1.529602887423
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.040771851	1.5296028874229997
ALLAN-HERNDON-DUDLEY SYNDROME	0.0405447	1.5210810563812593
ADAMS-OLIVER SYNDROME 5; AOS5	0.040529219000000005	1.5205002688594913
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.040505189999999996	1.5195987932855248
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.040284979000000005	1.5113373243264066
SMITH-KINGSMORE SYNDROME; SKS	0.040259257	1.5103723339100945
METACHROMATIC LEUKODYSTROPHY	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.040226297	1.509135801598391
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.040226297	1.509135801598391
EPISODIC ATAXIA, TYPE 1; EA1	0.040147840000000004	1.506192396999504
WILSON DISEASE	0.040147840000000004	1.506192396999504
NIEMANN-PICK DISEASE TYPE B	0.0399254	1.4978473045415142
WIDOW'S PEAK SYNDROME	0.0398601	1.4953974999312523
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0398601	1.4953974999312523
PROGEROID SYNDROME, PETTY TYPE	0.0397543	1.491428291236524
COSTELLO SYNDROME	0.03958295	1.4849998988939754
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	1.4841557855137169
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.039301854	1.4744542591278764
FG SYNDROME TYPE 1	0.039283473	1.4737646747704307
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938226
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039268894	1.4732177268161732
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.039085511	1.4663379026378622
GM2-GANGLIOSIDOSIS, AB VARIANT	0.039085511	1.4663379026378622
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.039085510999999996	1.466337902637862
PIERPONT SYNDROME	0.039066273	1.4656161669396657
ALSTROM SYNDROME; ALMS	0.039007054	1.4633944980389748
FABRY DISEASE	0.039002919000000004	1.4632393687577585
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.038726194	1.4528577120843311
MCLEOD SYNDROME; MCLDS	0.03872334	1.4527506409915643
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.03872334	1.4527506409915643
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.03872334	1.4527506409915643
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.038625379	1.4490755213985185
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.442927412214366
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.442927412214366
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.442927412214366
245800 LAURENCE-MOON SYNDROME	0.0384615	1.442927412214366
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.442927412214366
MUCOLIPIDOSIS III GAMMA	0.0384615	1.442927412214366
3Q13 MICRODELETION SYNDROME	0.0384615	1.442927412214366
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.442927412214366
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.442927412214366
MYCETOMA	0.0384615	1.442927412214366
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.442927412214366
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.442927412214366
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0384356	1.4419557439233126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0383041	1.437022370167578
ACROMELIC FRONTONASAL DYSPLASIA	0.038123973	1.4302646985744278
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698608
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0379793	1.4248371245716644
SHASHI-PENA SYNDROME; SHAPNS	0.037929911000000004	1.422984239427771
AL KAISSI SYNDROME; ALKAS	0.037929911000000004	1.422984239427771
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032174
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.037844813	1.4197916900751815
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310354
AICARDI-GOUTIERES SYNDROME 6	0.037582554	1.4099527420310354
HEREDITARY OROTIC ACIDURIA	0.037582554	1.4099527420310354
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.037578419	1.409797612749819
ADRENOLEUKODYSTROPHY	0.037578419	1.409797612749819
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.037578419	1.409797612749819
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.037578419	1.409797612749819
GM2 GANGLIOSIDOSIS, AB VARIANT	0.037578419	1.409797612749819
CORNELIA DE LANGE SYNDROME 3	0.037575523	1.409688965978742
NOONAN SYNDROME 7; NS7	0.037384357	1.4025171536031622
MELAS	0.03730002	1.3993531540409005
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.03726169199999999	1.3979152350347421
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.037257557	1.3977601057535256
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.037077154	1.3909920797029116
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.037037	1.3894856562064266
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.037037	1.3894856562064266
CANAVAN DISEASE	0.037037	1.3894856562064266
MARTSOLF SYNDROME	0.037037	1.3894856562064266
ACROCRANIOFACIAL DYSOSTOSIS	0.037037	1.3894856562064266
CRANIOECTODERMAL DYSPLASIA	0.037037	1.3894856562064266
KINDLER SYNDROME	0.037037	1.3894856562064266
KERATODERMA HEREDITARIUM MUTILANS	0.037037	1.3894856562064266
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.037037	1.3894856562064266
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.037037	1.3894856562064266
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.037037	1.3894856562064266
LEUKONYCHIA TOTALIS	0.037037	1.3894856562064266
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064266
CHARLIE M SYNDROME	0.037037	1.3894856562064266
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.037037	1.3894856562064266
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.037037	1.3894856562064266
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064266
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.037037	1.3894856562064266
LELIS SYNDROME	0.037037	1.3894856562064266
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.037037	1.3894856562064266
19P13.12 MICRODELETION SYNDROME	0.036968373	1.3869110353643366
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.036904730000000004	1.384523395015012
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.036675838	1.3759362483557145
SLC35A2-CDG	0.036649803999999994	1.3749595529005294
MOSAIC TRISOMY 9	0.036426954	1.3665990788209441
MENINGIOMA	0.03632481	1.3627670291714709
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.036259854	1.360330130116889
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.036259854	1.360330130116889
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.036255719000000006	1.3601750008356728
INHERITED CREUTZFELDT-JAKOB DISEASE	0.036255719000000006	1.3601750008356728
CHROMOSOME 9P DELETION SYNDROME	0.036238992000000005	1.3595474681907134
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346008
TETRASOMY 5P	0.035818873	1.3437862206706712
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.0357368	1.340707157672539
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.035714300000000004	1.3398630442922803
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.035714300000000004	1.3398630442922803
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.035714300000000004	1.3398630442922803
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.035714300000000004	1.3398630442922803
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.035714300000000004	1.3398630442922803
CLEIDOCRANIAL DYSPLASIA	0.035714300000000004	1.3398630442922803
SPINOCEREBELLAR ATAXIA TYPE 25	0.035714300000000004	1.3398630442922803
PRIMARY LATERAL SCLEROSIS, ADULT	0.035714300000000004	1.3398630442922803
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.035714300000000004	1.3398630442922803
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.035714300000000004	1.3398630442922803
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.035714300000000004	1.3398630442922803
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.035714300000000004	1.3398630442922803
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.035714300000000004	1.3398630442922803
NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME	0.035714300000000004	1.3398630442922803
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.035714300000000004	1.3398630442922803
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.035714300000000004	1.3398630442922803
EPIDERMOLYSIS BULLOSA SIMPLEX	0.035714300000000004	1.3398630442922803
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.035714300000000004	1.3398630442922803
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH	0.035714300000000004	1.3398630442922803
SPINOCEREBELLAR ATAXIA TYPE 8	0.035714300000000004	1.3398630442922803
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.035714300000000004	1.3398630442922803
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.035714300000000004	1.3398630442922803
PRETIBIAL DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.035714300000000004	1.3398630442922803
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.035714300000000004	1.3398630442922803
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.035714300000000004	1.3398630442922803
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735495
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735495
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735495
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.035576342	1.334687391238336
20Q11.2 MICRODUPLICATION SYNDROME	0.035569773	1.3344409476474508
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.3267813127703816
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.035277454	1.3234742641272788
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035227493	1.3215999197454518
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.035145111	1.3185092642568972
TRISOMY 8Q	0.035028354	1.3141289911040581
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.035024219	1.3139738618228418
ZIMMERMANN-LABAND SYNDROME	0.035024219	1.3139738618228418
22Q11.2 DELETION SYNDROME	0.035009952999999996	1.3134386564236074
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.034944352	1.310977559452125
DUPLICATION/INVERSION 15Q11	0.034836257	1.3069222511926109
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457728
NEONATAL MARFAN SYNDROME	0.0347319	1.30300717830267
3P25.3 MICRODELETION SYNDROME	0.034723409999999996	1.3026886661871855
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.034618434	1.2987503708002501
MOSAIC TRISOMY 8	0.0344828	1.2936619052794494
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502927
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502927
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03394444	1.2734647106396217
SPINOCEREBELLAR ATAXIA TYPE 34	0.03394444	1.2734647106396217
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.033934524	1.273092700493904
PULMONARY ARTERIOVENOUS MALFORMATION	0.033874719000000005	1.2708490471291765
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.033440257	1.2545497054663324
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.033438182000000004	1.2544718594545974
DERMATOMYOSITIS	0.0334169	1.2536734407453232
CORNELIA DE LANGE SYNDROME	0.033386139	1.2525194064479837
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0333333	1.250537090585784
AORTO-VENTRICULAR TUNNEL	0.0333333	1.250537090585784
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.0333333	1.250537090585784
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0333333	1.250537090585784
SECKEL SYNDROME 2; SCKL2	0.0333333	1.250537090585784
PERIPARTUM CARDIOMYOPATHY	0.0333333	1.250537090585784
CARCINOID SYNDROME	0.0333333	1.250537090585784
PARTIAL ATRIOVENTRICULAR CANAL	0.0333333	1.250537090585784
FAMILIAL ATRIAL MYXOMA	0.0333333	1.250537090585784
CONGENITAL AORTIC VALVE STENOSIS	0.0333333	1.250537090585784
DOUBLE OUTLET RIGHT VENTRICLE	0.0333333	1.250537090585784
CONGENITAL TRICUSPID STENOSIS	0.0333333	1.250537090585784
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0333333	1.250537090585784
FAMILIAL BICUSPID AORTIC VALVE	0.0333333	1.250537090585784
ANEURYSM OF SINUS OF VALSALVA	0.0333333	1.250537090585784
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0333333	1.250537090585784
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0333333	1.250537090585784
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.0333333	1.250537090585784
EISENMENGER SYNDROME	0.0333333	1.250537090585784
ALG13-CDG	0.033219637999999996	1.2462729299179183
OCULOCEREBRORENAL SYNDROME OF LOWE	0.033065799	1.2405014828821126
RETT SYNDROME, CONGENITAL VARIANT	0.032958999	1.2364947580371508
PEHO SYNDROME	0.032803653999999995	1.2306668116790926
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2306668116790926
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2306668116790926
HYDROXYKYNURENINURIA	0.032803653999999995	1.2306668116790926
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978766
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978766
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978766
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978766
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.032701822	1.2268464670684924
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544839
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2101997258544839
DESMOID TUMOR	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.0322222	1.2088528960610934
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.03204225	1.202101864826535
PERIVENTRICULAR NODULAR HETEROTOPIA	0.031623950000000005	1.1864088591837683
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.031421711	1.1788216304766501
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949704
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.030662772999999997	1.150349198450568
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.030582179	1.1473256218386316
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.030545011000000004	1.1459312215667448
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.030365029	1.1391789898153786
7Q11.23 MICRODUPLICATION SYNDROME	0.030355317000000003	1.1388146329643085
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.030216297	1.1335991377588162
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.03011502	1.1297996146115954
TOLUENE EMBRYOPATHY	0.030098964000000002	1.1291972553034428
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.1246966678568042
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.11464132665811
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.029608403999999998	1.1107933326447872
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.029553410000000002	1.1087301694788338
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.02948215	1.1060567686131786
POSTENCEPHALITIC PARKINSONISM	0.029471319000000003	1.1056504311899973
EPILEPSY, PYRIDOXINE-DEPENDENT	0.029302902000000002	1.099332073716084
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.029193952000000002	1.09524468914812
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.029037919000000002	1.0893909316787014
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.028964210999999997	1.0866256912772738
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.028923464	1.0850970207037003
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.028792299	1.080176214858294
TRISOMY 9P	0.028722754	1.0775671541902898
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.028700364000000003	1.0767271675865568
OTOFACIOCERVICAL SYNDROME	0.028700364000000003	1.0767271675865568
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.028556714000000004	1.0713379726054824
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.0636766495016527
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0632588696526497
DISTAL MONOSOMY 10P	0.0281772	1.0571000683656808
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.028168853999999997	1.05678695857583
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.028156457000000003	1.0563218708613829
MULTIPLE SYNOSTOSES SYNDROME	0.0279212	1.0474959339058474
GAUCHER DISEASE	0.027795809999999997	1.042791783828041
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623317
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623317
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623317
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623317
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623317
BRAIN-LUNG-THYROID SYNDROME	0.027231894000000003	1.0216358264528405
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.027231894000000003	1.0216358264528405
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.027227759000000004	1.021480697171624
ALZHEIMER DISEASE 3; AD	0.027227759000000004	1.021480697171624
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.027227759000000004	1.021480697171624
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.027227759000000004	1.021480697171624
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.027196718999999998	1.020316195868369
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.027189239000000004	1.020035575064621
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.027103113	1.0168044591095913
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.02697786	1.0121054487443666
ROIFMAN SYNDROME; RFMN	0.026920172	1.0099412170696835
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.026906047	1.009411301447632
2Q37 MICRODELETION SYNDROME	0.026842632999999998	1.0070322522967108
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.026686340000000003	1.0011687406282315
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.026686340000000003	1.0011687406282315
MAST SYNDROME	0.026686340000000003	1.0011687406282315
19P13.3 MICRODUPLICATION SYNDROME	0.026556833999999998	0.9963101740760627
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.026391799	0.9901186962222401
AYMÉ-GRIPP SYNDROME	0.026169053999999997	0.9817621613384293
DUBOWITZ SYNDROME	0.026104378999999997	0.9793358043220632
15Q11Q13 MICRODUPLICATION SYNDROME	0.026086973000000003	0.9786827982110953
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.025961538000000003	0.9739769599065281
CADASIL	0.025541419000000003	0.9582157123864864
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.025541419000000003	0.9582157123864864
FLYNN-AIRD SYNDROME	0.025541419000000003	0.9582157123864864
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.025541419000000003	0.9582157123864864
SNEDDON SYNDROME	0.025541419000000003	0.9582157123864864
FLYNN-AIRD SYNDROME	0.025541419000000003	0.9582157123864864
PERLMAN SYNDROME	0.025486654	0.9561611404189364
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.025388259999999996	0.9524697763328392
MONOSOMY 22Q13.3	0.025335622999999998	0.9504950387329868
CLASSIC MYCOSIS FUNGOIDES	0.025306959999999996	0.9494197133188375
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.025306959999999996	0.9494197133188375
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0252799	0.948404526293513
KAPUR-TORIELLO SYNDROME	0.025135409000000004	0.9429837802300922
ALZHEIMER DISEASE 4	0.025	0.9379037558430938
CARIBBEAN PARKINSONISM	0.025	0.9379037558430938
MOHR-TRANEBJAERG SYNDROME	0.025	0.9379037558430938
MASA SYNDROME	0.025	0.9379037558430938
PROGRESSIVE SUPRANUCLEAR PALSY	0.025	0.9379037558430938
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.025	0.9379037558430938
CREUTZFELDT-JAKOB DISEASE; CJD	0.025	0.9379037558430938
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.025	0.9379037558430938
MASA SYNDROME	0.025	0.9379037558430938
POLYMYOSITIS	0.02496148	0.9364586337360907
TYROSINEMIA TYPE 2	0.024961429	0.9364567204124288
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.024895558999999998	0.9339855315965333
PITT-HOPKINS-LIKE SYNDROME	0.024820628999999997	0.9311744464595203
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361383
SMITH-LEMLI-OPITZ SYNDROME	0.024540923000000003	0.9206809541422466
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.024532359999999996	0.920359703347795
SAETHRE-CHOTZEN SYNDROME	0.024514519	0.9196903777114752
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.024495692	0.9189840611510249
RAPID-ONSET DYSTONIA-PARKINSONISM	0.024465897	0.9178662674548113
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.024424071	0.9162971169551355
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.02442001	0.9161447638690362
JOHANSON-BLIZZARD SYNDROME; JBS	0.024410297999999997	0.9157804070179663
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228372999999997	0.9089552813866961
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.024049913000000003	0.902260149215986
COOPER-JABS SYNDROME	0.0238813	0.895934438576627
SIALIDOSIS TYPE 2	0.023865911	0.8953571025406802
MCDONOUGH SYNDROME	0.02370476	0.8893113374143653
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02365399	0.8874066424669992
9Q33.3Q34.11 MICRODELETION SYNDROME	0.023613508999999998	0.8858879511893878
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.023567554	0.8841638965053972
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.023542714	0.8832319953335913
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023540142	0.8831355037951902
EARLY-ONSET LAFORA BODY DISEASE	0.023504359	0.8817930633913769
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.023474742	0.8806819475699047
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023474742	0.8806819475699047
TRISOMY 20P	0.02334681	0.875882431438204
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.023330069000000002	0.8752543735671412
CONGENITAL MYASTHENIC SYNDROME	0.023330069000000002	0.8752543735671412
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.023203072999999998	0.8704899725520592
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.022993969	0.8626451954735868
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.02296294	0.8614811068479845
DYSTONIA 12; DYT12	0.02296294	0.8614811068479845
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.02296294	0.8614811068479845
CK SYNDROME	0.022881811	0.8584374590956727
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.022801670000000003	0.855430877299792
JUVENILE DERMATOMYOSITIS	0.022801670000000003	0.855430877299792
TRISOMY 13	0.022535229000000004	0.8454350367153683
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064704
JACOBSEN SYNDROME	0.022495723000000002	0.8439529236842347
ROIFMAN SYNDROME	0.022443698	0.8420011459683253
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.022178827	0.8320642057397687
CLASSICAL EHLERS-DANLOS SYNDROME	0.02211082	0.8295128449108238
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.022053014	0.8273441863304131
AMISH INFANTILE EPILEPSY SYNDROME	0.02203305	0.826595213907147
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.021920273	0.8223642550322384
CUTIS LAXA	0.021904413999999997	0.8217692864056816
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.021873781000000002	0.8206200541755723
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.021869682999999997	0.8204663129919142
RICHARDS-RUNDLE SYNDROME; RRNS	0.021822154	0.8186832078874556
HUNTINGTON DISEASE-LIKE 3	0.021818019	0.8185280786062392
SCHWARTZ-JAMPEL SYNDROME	0.0218174	0.8185048561092445
FUMARASE DEFICIENCY; FMRD	0.021548402	0.8084130867286734
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.021528592	0.8076698917925432
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.021520032999999997	0.8073487910626927
CORNELIA DE LANGE SYNDROME 1	0.021492009	0.806297438468543
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02140106	0.802885382120936
TREACHER-COLLINS SYNDROME	0.021378854	0.802052298488846
BENIGN FAMILIAL INFANTILE EPILEPSY	0.021374719	0.8018971692076295
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.021374719	0.8018971692076295
L-2-HYDROXYGLUTARIC ACIDURIA	0.021374719	0.8018971692076295
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.02133566	0.8004318258956503
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.7990607606692087
PELGER-HUET ANOMALY; PHA	0.021295264	0.798916323490809
NOONAN SYNDROME	0.021294140000000003	0.7988741553379465
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997381
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.7982161220628466
NEUROLEPTIC MALIGNANT SYNDROME	0.0212766	0.7982161220628466
BECKWITH-WIEDEMANN SYNDROME	0.02122387	0.7962378954610225
NEUROFERRITINOPATHY	0.02111533	0.7921658925146541
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.021097992000000003	0.7915154375019018
MONOSOMY 13Q14	0.0210064	0.7880792582696946
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0210064	0.7880792582696946
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0210064	0.7880792582696946
ROBERTS SYNDROME	0.020997114000000004	0.7877308832986244
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0208333	0.781585212664237
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.0208333	0.781585212664237
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.0208333	0.781585212664237
CYSTINOSIS	0.0208333	0.781585212664237
FAMILIAL CERVICAL ARTERY DISSECTION	0.0208333	0.781585212664237
RING CHROMOSOME 14 SYNDROME	0.020810252	0.7807205404336502
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.020744137000000003	0.7782401601609477
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751292
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751292
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751292
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.020715703999999998	0.777173463461352
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.020595210000000003	0.7726529924550898
PYRIDOXINE-DEPENDENT EPILEPSY	0.020586864	0.772339882665239
BETA-UREIDOPROPIONASE DEFICIENCY	0.020586864	0.772339882665239
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.020586864	0.772339882665239
NASU-HAKOLA DISEASE	0.020582729	0.7721847533840226
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.020569338000000003	0.7716823746162429
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.02054506	0.7707715575208685
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.020505813999999997	0.7692991986887956
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.02045156	0.7672637974740153
RENAL TUBULAR DYSGENESIS	0.02045156	0.7672637974740153
DISTAL MONOSOMY 17Q	0.02045156	0.7672637974740153
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443214	0.7669506876841646
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.020344042	0.7632301360331858
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.020317213000000004	0.7622236152385654
NIEMANN-PICK DISEASE TYPE C	0.020317213	0.7622236152385652
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.020191778000000004	0.7575177769339982
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.020169934	0.7566982741482926
FETAL HYDANTOIN SYNDROME	0.020153354000000002	0.7560762563774175
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.020153354000000002	0.7560762563774175
FETAL ALCOHOL SYNDROME	0.020153354000000002	0.7560762563774175
48,XYYY SYNDROME	0.020153354000000002	0.7560762563774175
QAZI-MARKOUIZOS SYNDROME	0.020149219000000003	0.7559211270962011
CHIME SYNDROME	0.020149219000000003	0.7559211270962011
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.020149219000000003	0.7559211270962011
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.020149219000000003	0.7559211270962011
KABUKI SYNDROME	0.020149219000000003	0.7559211270962011
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.020146499999999998	0.7558191206837154
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.020146499999999998	0.7558191206837154
PITT-HOPKINS SYNDROME	0.019992797	0.7500527758443415
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628778
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.019882139	0.745901313691778
CURRY-JONES SYNDROME	0.019786734	0.7423220853787297
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.019785089999999998	0.7422604088277454
MARINESCO-SJÖGREN SYNDROME	0.019775794000000003	0.7419116586951728
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.019623960000000003	0.7362154315405856
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.019623960000000003	0.7362154315405856
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.019615653	0.735903784880594
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0196078	0.7356091705528086
ACHALASIA-MICROCEPHALY SYNDROME	0.0196078	0.7356091705528086
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.0196078	0.7356091705528086
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0196078	0.7356091705528086
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.0196078	0.7356091705528086
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0196078	0.7356091705528086
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.0196078	0.7356091705528086
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0196078	0.7356091705528086
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.0196078	0.7356091705528086
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0196078	0.7356091705528086
IVIC SYNDROME	0.0196078	0.7356091705528086
CROSSED POLYSYNDACTYLY	0.0196078	0.7356091705528086
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.0196078	0.7356091705528086
RADIAL HYPOPLASIA-TRIPHALANGEAL THUMBS-HYPOSPADIAS-MAXILLARY DIASTEMA SYNDROME	0.0196078	0.7356091705528086
DERMATOGLYPHICS--PALMAR TRIRADIUS D, ABSENCE OF	0.0196078	0.7356091705528086
POLAND SYNDROME	0.0196078	0.7356091705528086
DERMAL RIDGES, NELSON SYNDROME	0.0196078	0.7356091705528086
DERMATOGLYPHICS--FINGERPRINT PATTERN	0.0196078	0.7356091705528086
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.019473463	0.7305693634788608
COFFIN-SIRIS SYNDROME 6; CSS6	0.019450972	0.7297255877439541
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019411652	0.7282504527167641
HHHH SYNDROME	0.019409319	0.7281629275382688
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7281629275382688
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382688
EMANUEL SYNDROME	0.019268051	0.7228630960270511
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.019230240000000003	0.721444572870564
KENNEDY DISEASE	0.019230240000000003	0.721444572870564
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.019230240000000003	0.721444572870564
PRIMARY DYSTONIA, DYT17 TYPE	0.019230240000000003	0.721444572870564
SPINOCEREBELLAR ATAXIA 20	0.019230240000000003	0.721444572870564
DYSTONIA 16	0.019230240000000003	0.721444572870564
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.019103648999999997	0.7166953658963263
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.019097186999999998	0.716452936533516
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395409
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.019050992000000003	0.7147198779734694
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.018985071	0.7122467758339119
16P13.2 MICRODELETION SYNDROME	0.018955923	0.7111532550868994
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.018880714	0.7083317029439712
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948764
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948764
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948764
THROMBOCYTOPENIA 3	0.0188679	0.7078509709948764
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7078509709948764
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948764
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948764
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948764
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948764
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948764
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948764
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948764
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7078509709948764
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948764
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948764
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948764
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948764
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948764
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7078509709948764
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948764
TOE, MISSHAPEN	0.0188679	0.7078509709948764
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.7078509709948764
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7078509709948764
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948764
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948764
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948764
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948764
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948764
RAYNAUD DISEASE	0.0188679	0.7078509709948764
CARPAL DISPLACEMENT	0.0188679	0.7078509709948764
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948764
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7078509709948764
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948764
NEPHROSIALIDOSIS	0.0188679	0.7078509709948764
KNUCKLE PADS	0.0188679	0.7078509709948764
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7078509709948764
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948764
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948764
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948764
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948764
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7078509709948764
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.018830488	0.7064474167823322
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01881384	0.7058228479132411
XQ12-Q13.3 DUPLICATION SYNDROME	0.01869322	0.7012976498720495
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.018681203	0.7008468182946908
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.018661648	0.7001131899768703
2Q31.1 MICRODELETION SYNDROME	0.018614572999999995	0.6983471172046176
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.018582394000000002	0.6971398850062469
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01856223	0.696383409352934
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149319
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.018505438000000003	0.6942527921488605
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.018450114	0.6921772486533299
1P36 DELETION SYNDROME	0.018411313000000002	0.6907215845081112
TETRASOMY 9P	0.018370211	0.6891795957012046
YUNIS-VARON SYNDROME	0.018339258	0.6880183583030202
SAY-BARBER-MILLER SYNDROME	0.018109594	0.6794022491757422
OROFACIODIGITAL SYNDROME TYPE 4	0.018073153999999998	0.6780351606612253
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.018073153999999998	0.6780351606612253
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.018071979000000002	0.6779910791847007
TURNPENNY-FRY SYNDROME; TPFS	0.018002944	0.6754011517533156
IMMUNODEFICIENCY 49; IMD49	0.017948591	0.673362036439662
KOOLEN-DE VRIES SYNDROME; KDVS	0.017892731000000002	0.6712663842876062
16P11.2P12.2 MICRODELETION SYNDROME	0.017838504	0.6692319960088822
PROTEUS SYNDROME	0.017813019	0.6682758969201755
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01780627	0.6680227004222481
LATERAL MENINGOCELE SYNDROME	0.017744738	0.6657142566660667
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.017627371	0.6613110986615852
MOEBIUS SYNDROME; MBS	0.01755934	0.6587588374450347
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.017544841	0.6582148907827959
DYSTONIA 7, TORSION	0.0175439	0.6581795880854262
GOOD SYNDROME	0.0175439	0.6581795880854262
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0175439	0.6581795880854262
DYSTONIA 23; DYT23	0.0175439	0.6581795880854262
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.0175439	0.6581795880854262
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.0175439	0.6581795880854262
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0175439	0.6581795880854262
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.0175439	0.6581795880854262
MEDULLARY THYROID CARCINOMA	0.0175439	0.6581795880854262
LARYNGEAL NEUROENDOCRINE TUMOR	0.0175439	0.6581795880854262
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.0175439	0.6581795880854262
ANAPLASTIC THYROID CARCINOMA	0.0175439	0.6581795880854262
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.0175439	0.6581795880854262
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0175439	0.6581795880854262
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0175439	0.6581795880854262
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0175439	0.6581795880854262
NON-FUNCTIONING PARAGANGLIOMA	0.0175439	0.6581795880854262
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0175439	0.6581795880854262
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0175439	0.6581795880854262
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.0175439	0.6581795880854262
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0175439	0.6581795880854262
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0175439	0.6581795880854262
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.017527599999999997	0.6575680748366163
MOSAIC MONOSOMY X	0.017527599999999997	0.6575680748366163
TRISOMY 1Q	0.017527599999999997	0.6575680748366163
MONOSOMY X	0.017527599999999997	0.6575680748366163
FIBROCHONDROGENESIS 1; FBCG1	0.017527599999999997	0.6575680748366163
TURNER SYNDROME	0.017527599999999997	0.6575680748366163
PELIZAEUS-MERZBACHER DISEASE	0.017491789	0.6562245839805966
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.017469201	0.6553771691791171
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.017437748	0.6541971737058159
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.017329094	0.6501208939183208
SCALP-EAR-NIPPLE SYNDROME; SENS	0.017271599999999998	0.6479639403767831
OTOONYCHOPERONEAL SYNDROME	0.017271599999999998	0.6479639403767831
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397247
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397247
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397247
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397247
MOSAIC TRISOMY 15	0.0172414	0.6468309526397247
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397247
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397247
SICKLE CELL ANEMIA	0.0172414	0.6468309526397247
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397247
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397247
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397247
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397247
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397247
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397247
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397247
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397247
PALMOMENTAL REFLEX	0.0172414	0.6468309526397247
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397247
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397247
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397247
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397247
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397247
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397247
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397247
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397247
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397247
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397247
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397247
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397247
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397247
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397247
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397247
MOTION SICKNESS	0.0172414	0.6468309526397247
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397247
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397247
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397247
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397247
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397247
TRANSSEXUALITY	0.0172414	0.6468309526397247
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397247
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397247
CERVICAL RIB	0.0172414	0.6468309526397247
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397247
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397247
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397247
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397247
DIASTEMATOMYELIA	0.0172414	0.6468309526397247
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397247
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397247
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397247
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397247
BARDET-BIEDL SYNDROME 1; BBS1	0.017222644000000002	0.646127299725941
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.6450939548839032
SMITH-MAGENIS SYNDROME	0.017051563000000002	0.6397089992278053
PONTINE TEGMENTAL CAP DYSPLASIA	0.017039311	0.6392493513551417
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.017039311	0.6392493513551417
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.017039311	0.6392493513551417
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.017003828000000002	0.6379181657963985
FUCOSIDOSIS	0.016959973	0.6362728950278984
OLIVER SYNDROME	0.01694901	0.6358616054728862
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.016858023	0.6324481235115703
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016847542	0.6320549167409707
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.016792813	0.6300016953548292
WEAVER SYNDROME	0.016674553999999998	0.6255650729443392
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.016674553999999998	0.6255650729443392
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.016674553999999998	0.6255650729443392
2P15P16.1 MICRODELETION SYNDROME	0.016640232	0.6242774436360174
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.016559703000000002	0.621256305573846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.016508373	0.6193306015823489
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016497892	0.6189373948117491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.016497892	0.6189373948117491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.016497892	0.6189373948117491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.016497892	0.6189373948117491
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.016432492	0.6164838385864636
HAREL-YOON SYNDROME; HAYOS	0.016432492	0.6164838385864636
MENTAL RETARDATION, X-LINKED 41	0.016432492	0.6164838385864636
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.016420960999999998	0.6160512398581185
HEREDITARY METHEMOGLOBINEMIA	0.016414419	0.6158058092032895
INTELLECTUAL DISABILITY, WOLFF TYPE	0.016414419	0.6158058092032895
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01639194	0.6149624836621858
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0163217	0.612327349269769
DOWN SYNDROME	0.0163217	0.612327349269769
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0163217	0.612327349269769
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.016313413	0.6120164529327821
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965499
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965499
11Q22.2Q22.3 MICRODELETION SYNDROME	0.016220113	0.6085161961159756
C SYNDROME	0.016161049	0.606300342218571
ADAMS-OLIVER SYNDROME 6; AOS6	0.016128999999999998	0.6050979871197303
NON-DISTAL TRISOMY 13Q	0.016128999999999998	0.6050979871197303
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.016128999999999998	0.6050979871197303
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.016128999999999998	0.6050979871197303
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.016128999999999998	0.6050979871197303
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.6050979871197303
ELLIS VAN CREVELD SYNDROME	0.016128999999999998	0.6050979871197303
SCHNECKENBECKEN DYSPLASIA	0.016128999999999998	0.6050979871197303
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.016128999999999998	0.6050979871197303
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.016128999999999998	0.6050979871197303
NAIL-PATELLA SYNDROME	0.016128999999999998	0.6050979871197303
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.016128999999999998	0.6050979871197303
ISOTRETINOIN SYNDROME	0.016128999999999998	0.6050979871197303
CAMPTOBRACHYDACTYLY	0.016128999999999998	0.6050979871197303
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.016128999999999998	0.6050979871197303
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.016128999999999998	0.6050979871197303
ULNAR-MAMMARY SYNDROME	0.016128999999999998	0.6050979871197303
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.016123971	0.604909318400205
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.016071310999999998	0.602933717928897
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015930494	0.5976508062014347
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.015930174	0.59763880103336
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01589435	0.5962948224673872
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015879542	0.5957392833147261
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.015876351	0.5956195692793302
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.595493852659897
LICHEN PLANUS PEMPHIGOIDES	0.015872999999999998	0.595493852659897
PILI TORTI	0.015872999999999998	0.595493852659897
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.015872999999999998	0.595493852659897
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.595493852659897
CHILBLAIN LUPUS 1	0.015872999999999998	0.595493852659897
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.595493852659897
ERYTHROKERATODERMIA VARIABILIS	0.015872999999999998	0.595493852659897
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.595493852659897
SILLENCE SYNDROME	0.015872999999999998	0.595493852659897
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.595493852659897
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.595493852659897
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.595493852659897
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.595493852659897
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.595493852659897
ALKAPTONURIA	0.015872999999999998	0.595493852659897
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.595493852659897
MONILETHRIX	0.015872999999999998	0.595493852659897
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.595493852659897
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.595493852659897
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.595493852659897
ACRODYSOSTOSIS	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.015872999999999998	0.595493852659897
TOE, ROTATED FIFTH	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.595493852659897
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.595493852659897
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.595493852659897
FLOTCH SYNDROME	0.015872999999999998	0.595493852659897
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.595493852659897
ADACTYLIA, UNILATERAL	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.595493852659897
LUNULAE OF FINGERNAILS	0.015872999999999998	0.595493852659897
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.015872999999999998	0.595493852659897
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.595493852659897
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.595493852659897
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.015872999999999998	0.595493852659897
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.595493852659897
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.015872999999999998	0.595493852659897
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.015872999999999998	0.595493852659897
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.595493852659897
GROWTH HORMONE INSENSITIVITY SYNDROME	0.015872999999999998	0.595493852659897
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.015832017	0.5939563282748684
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01582094	0.5935407618787293
SILVER-RUSSELL SYNDROME	0.01582094	0.5935407618787293
LICHTENSTEIN SYNDROME	0.01570584	0.5892226529868277
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015642754	0.5868559091331831
PEHO-LIKE SYNDROME; PEHOL	0.015536353999999999	0.5828641907483149
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.015536353999999999	0.5828641907483149
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015536353999999999	0.5828641907483149
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230293
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230293
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.015384939999999998	0.5771837203768257
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.015260002000000002	0.5724965275989249
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.015229150999999998	0.5713391168480642
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015201556999999997	0.5703038961985148
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.015155202	0.5685648350544306
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015097199999999998	0.5663888233085741
ALAZAMI-YUAN SYNDROME	0.015085893999999999	0.5659646657140317
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.015049564	0.5646017039760405
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.014990799999999999	0.5623971049237059
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.5623971049237059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014990799999999999	0.5623971049237059
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.014959602	0.5612266760687143
WIEACKER-WOLFF SYNDROME	0.014941410999999998	0.5605442197798125
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.014799799999999998	0.5552315202290646
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014754951999999998	0.5535489959233826
JOUBERT SYNDROME 32; JBTS32	0.014687731999999998	0.5510271603046717
SPINOCEREBELLAR ATAXIA TYPE 29	0.014687731999999998	0.5510271603046717
PEROXISOME BIOGENESIS DISORDER 5B	0.014687731999999998	0.5510271603046717
EPILEPSY, HOT WATER, 1	0.014660137999999998	0.5499919396551223
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01461801	0.5484114592780761
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.014533773000000002	0.545251211330838
RECOMBINANT 8 SYNDROME	0.014533773000000002	0.545251211330838
MONOSOMY 9P	0.014533773000000002	0.545251211330838
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.014460363	0.5424971507421802
JOUBERT SYNDROME 35; JBTS35	0.014399991999999999	0.54023226323642
JOUBERT SYNDROME 2	0.014399991999999999	0.54023226323642
OROFACIODIGITAL SYNDROME XVI; OFD16	0.014399991999999999	0.54023226323642
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.014399991999999999	0.54023226323642
JOUBERT SYNDROME 1	0.014399991999999999	0.54023226323642
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014372449999999998	0.5391989934266829
3C SYNDROME	0.014337314	0.5378808259720708
CATEL-MANZKE SYNDROME; CATMANS	0.014334833	0.537787748403341
COFFIN-SIRIS SYNDROME 1; CSS1	0.014334833	0.537787748403341
PETERS-PLUS SYNDROME; PTRPLS	0.014334833	0.537787748403341
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.014262852000000001	0.5350872983933673
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014262852000000001	0.5350872983933673
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.014262852000000001	0.5350872983933673
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.014253014	0.5347182145073679
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.01421911	0.5334462669498437
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.014176652999999999	0.5318534437593705
SPINOCEREBELLAR ATAXIA 2; SCA2	0.014142177999999998	0.5305600744800628
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.014142177999999998	0.5305600744800628
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.014092363	0.5286912074561699
PROPIONIC ACIDEMIA	0.014092363	0.5286912074561699
ROIFMAN-CHITAYAT SYNDROME	0.014078314	0.5281641430615363
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014024741	0.526154290345065
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.014012657000000001	0.5257009451856408
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.014012657	0.5257009451856407
FETAL TRIMETHADIONE SYNDROME	0.013992354000000002	0.5249392547874455
JOUBERT SYNDROME	0.013979872999999999	0.5244710157163782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.013973410999999998	0.524228586353568
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.013948371000000001	0.5232891819517156
SIMPSON-GOLABI-BEHMEL SYNDROME	0.013907483	0.5217552216009591
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.013907483	0.5217552216009591
ZIMMERMANN-LABAND SYNDROME 1	0.013906537	0.521719731322838
JOUBERT SYNDROME 3; JBTS3	0.013854437999999998	0.519765177411811
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01375291	0.5159562377108817
DESANTO-SHINAWI SYNDROME	0.013750021000000001	0.5158478535528566
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013732181999999999	0.515178602948837
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013726193999999999	0.5149539562412375
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.013726193999999999	0.5149539562412375
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.013722058999999998	0.514798826960021
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5139187355916881
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916881
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916881
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916881
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916881
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916881
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916881
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916881
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.013570734000000001	0.5091216955259029
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.013542810999999998	0.5080741320629265
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.013542810999999998	0.5080741320629265
COACH SYNDROME	0.013542810999999998	0.5080741320629265
HYPERPROLINEMIA, TYPE I	0.013542810999999998	0.5080741320629265
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01353276	0.5076970572369274
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.013471238	0.5053889886422482
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.013434318999999998	0.5040039298917693
SCHAAF-YANG SYNDROME; SHFYNG	0.013399653000000001	0.5027033950277672
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.013374829999999999	0.5017721316305154
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.013366064	0.5014432650575666
BRANCHIOOCULOFACIAL SYNDROME	0.013361929	0.5012881357763501
ASPARTYLGLUCOSAMINURIA	0.013361929	0.5012881357763501
PALLISTER-KILLIAN SYNDROME	0.013352217	0.5009237789252802
CAMOS SYNDROME	0.013338859000000002	0.5004226381904582
VASCULAR EHLERS-DANLOS SYNDROME	0.013222414	0.4960540700764922
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.013180639999999999	0.4944868704166286
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.013180639999999999	0.4944868704166286
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.013180639999999999	0.4944868704166286
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.013180639999999999	0.4944868704166286
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.013180639999999999	0.4944868704166286
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.013180639999999999	0.4944868704166286
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.013180639999999999	0.4944868704166286
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.013180639999999999	0.4944868704166286
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.013135173000000002	0.49278112361395193
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.013135173000000002	0.49278112361395193
15Q24 MICRODELETION SYNDROME	0.013135173000000002	0.49278112361395193
MOSAIC TRISOMY 14	0.013135173000000002	0.49278112361395193
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.013120771	0.4922408160182858
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013061763	0.49002706302529425
KAGAMI-OGATA SYNDROME	0.013061763	0.49002706302529425
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.013061763	0.49002706302529425
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.013016414	0.4883257431283451
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.013011872999999998	0.48815538229013367
JOUBERT SYNDROME 15	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 8	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 21	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 7	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 6	0.013001391999999999	0.48776217551953405
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 31; JBTS31	0.013001391999999999	0.48776217551953405
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013001391999999999	0.48776217551953405
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 27	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 28	0.013001391999999999	0.48776217551953405
JOUBERT SYNDROME 25	0.013001391999999999	0.48776217551953405
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.012962591	0.48630651137431535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.012962591	0.48630651137431535
HURLER SYNDROME	0.012949134	0.4858016565406202
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.012944998999999999	0.48564652725940366
FRAGILE X SYNDROME	0.012934579000000002	0.48525560897396836
KLEEFSTRA SYNDROME	0.012924867	0.4848912521228984
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.012854099	0.48223630920315824
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.01282051	0.4809761792329577
SPINOCEREBELLAR ATAXIA 34; SCA34	0.01279744	0.4801106816470657
FLOATING-HARBOR SYNDROME	0.012663994000000001	0.47510430146297616
WILLIAMS-BEUREN SYNDROME; WBS	0.012652618	0.4746775177379173
IMMUNODEFICIENCY 23; IMD23	0.012627392	0.47373113533212136
14Q22Q23 MICRODELETION SYNDROME	0.012593754000000002	0.47246916707055947
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.012593754000000002	0.47246916707055947
DISTAL TRISOMY 18Q	0.012593754000000002	0.47246916707055947
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.012593754000000002	0.47246916707055947
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.012589619000000002	0.472314037789343
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.012589619000000002	0.472314037789343
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.012589619000000002	0.472314037789343
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.012589619000000002	0.472314037789343
NEONATAL ADRENOLEUKODYSTROPHY	0.012589619000000002	0.472314037789343
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.012589619000000002	0.472314037789343
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.012589619000000002	0.472314037789343
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.012589619000000002	0.472314037789343
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.012589619000000002	0.472314037789343
GAUCHER DISEASE, TYPE II	0.012581272999999999	0.4720009279994922
JOUBERT SYNDROME WITH OCULAR DEFECT	0.012581272999999999	0.4720009279994922
JOUBERT SYNDROME WITH RENAL DEFECT	0.012581272999999999	0.4720009279994922
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012574810999999998	0.47175849863668196
KLEEFSTRA SYNDROME 2; KLEFS2	0.012574810999999998	0.47175849863668196
SIMOSA CRANIOFACIAL SYNDROME	0.0125097	0.469315784578814
POLYVALVULAR HEART DISEASE SYNDROME	0.0125097	0.469315784578814
BRESEK SYNDROME	0.012470453999999999	0.46784342574674126
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012470453999999999	0.46784342574674126
RAINE SYNDROME	0.012470453999999999	0.46784342574674126
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.012455837999999999	0.4672950896949251
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.012455837999999999	0.4672950896949251
JOUBERT SYNDROME 4	0.012455837999999999	0.4672950896949251
JOUBERT SYNDROME 5	0.012455837999999999	0.4672950896949251
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.012455837999999999	0.4672950896949251
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012421172000000001	0.4659945548309229
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.012421172000000001	0.4659945548309229
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.012417037	0.4658394255497064
HURLER-SCHEIE SYNDROME	0.012403579999999999	0.46533457071601125
FLOATING-HARBOR SYNDROME	0.012403579999999999	0.46533457071601125
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.012403579999999999	0.46533457071601125
CRANIOFACIOFRONTODIGITAL SYNDROME	0.012403579999999999	0.46533457071601125
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.012403579999999999	0.46533457071601125
RIN2 SYNDROME	0.012403579999999999	0.46533457071601125
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.012403579999999999	0.46533457071601125
AARSKOG-SCOTT SYNDROME	0.012394813999999999	0.46500570414306236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.012304921	0.46163326485010225
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.012207273	0.4579698878120796
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012167999	0.45649647852780034
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.012167999	0.45649647852780034
PENOSCROTAL TRANSPOSITION	0.012048200000000002	0.45200208124595054
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.012048200000000002	0.45200208124595054
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.012048200000000002	0.45200208124595054
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.012048200000000002	0.45200208124595054
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.012048200000000002	0.45200208124595054
MICROPHTHALMIA WITH LIMB ANOMALIES	0.012048200000000002	0.45200208124595054
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.012048200000000002	0.45200208124595054
CLEIDORHIZOMELIC SYNDROME	0.012048200000000002	0.45200208124595054
SHORT RIB-POLYDACTYLY SYNDROME	0.012048200000000002	0.45200208124595054
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.012048200000000002	0.45200208124595054
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.012048200000000002	0.45200208124595054
NON-DISTAL MONOSOMY 10Q	0.012048200000000002	0.45200208124595054
LAURENCE-MOON SYNDROME	0.012048200000000002	0.45200208124595054
FRONTONASAL DYSPLASIA	0.012048200000000002	0.45200208124595054
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.012048200000000002	0.45200208124595054
BÖÖK SYNDROME	0.012048200000000002	0.45200208124595054
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.012048200000000002	0.45200208124595054
SHELDON-HALL SYNDROME	0.012048200000000002	0.45200208124595054
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.45200208124595054
MCDONOUGH SYNDROME	0.012048200000000002	0.45200208124595054
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.012048200000000002	0.45200208124595054
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.012048200000000002	0.45200208124595054
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.012048200000000002	0.45200208124595054
PROLIDASE DEFICIENCY	0.012048200000000002	0.45200208124595054
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.012048200000000002	0.45200208124595054
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.012039854	0.45168897145609976
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609976
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609976
MECKEL SYNDROME 13; MKS13	0.012039854	0.45168897145609976
JOUBERT SYNDROME 17; JBTS17	0.012039854	0.45168897145609976
JOUBERT SYNDROME 33; JBTS33	0.012039854	0.45168897145609976
CRANIOSYNOSTOSIS 6; CRS6	0.012033391999999999	0.4514465420932894
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.012029256999999998	0.451291412812073
ZUNICH NEUROECTODERMAL SYNDROME	0.012029256999999998	0.451291412812073
XQ28 (MECP2) DUPLICATION	0.012001053000000001	0.4502333073108811
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	0.4492480206572928
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.011963329	0.44881804805946407
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.011963329	0.44881804805946407
FIBROCHONDROGENESIS	0.011924899999999999	0.4473763399221323
ATELOSTEOGENESIS TYPE II	0.011924899999999999	0.4473763399221323
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.011924899999999999	0.4473763399221323
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.011924899999999999	0.4473763399221323
NEUROFACIODIGITORENAL SYNDROME	0.011924899999999999	0.4473763399221323
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.011864930999999999	0.4451265339087661
MACS SYNDROME	0.01184926	0.44453861831845354
21Q22.11Q22.12 MICRODELETION SYNDROME	0.011846779000000002	0.44444554074972364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.011794098	0.4424691524392608
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01170151	0.43899560712142077
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01169108	0.438604313674483
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.011652519	0.4371576534053205
GM1 GANGLIOSIDOSIS	0.011652519	0.4371576534053205
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.4356852945732476
6Q TERMINAL DELETION SYNDROME	0.011613272999999999	0.4356852945732476
DUANE RETRACTION SYNDROME	0.011613272999999999	0.4356852945732476
MUENKE SYNDROME	0.011613272999999999	0.4356852945732476
6Q25 MICRODELETION SYNDROME	0.011613272999999999	0.4356852945732476
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011589493	0.43479316052068967
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.43122188563149083
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.011494299999999999	0.43122188563149083
OCULAR MOTOR APRAXIA	0.011494299999999999	0.43122188563149083
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.011494299999999999	0.43122188563149083
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.011494299999999999	0.43122188563149083
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.011494299999999999	0.43122188563149083
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.011494299999999999	0.43122188563149083
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.43122188563149083
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.43122188563149083
DESMOSTEROLOSIS	0.011494299999999999	0.43122188563149083
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.011491154	0.4311038598228556
SULFOCYSTEINURIA	0.011482471	0.4307781070903761
INFANTILE DYSTONIA-PARKINSONISM	0.011459634000000002	0.4299213507674887
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.011433954	0.4289579360294866
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01142191	0.42850609151607166
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.011378114	0.4268630342004354
ECTODERMAL DYSPLASIA SYNDROME	0.011373979	0.426707904919219
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.011373979	0.426707904919219
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011307771000000001	0.42422403564454464
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.41684569686192796
FUTCHER LINE	0.0111111	0.41684569686192796
GLOMUVENOUS MALFORMATIONS	0.0111111	0.41684569686192796
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.41684569686192796
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.41684569686192796
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.41684569686192796
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.41684569686192796
PIGMENTED PURPURIC ERUPTION	0.0111111	0.41684569686192796
CAROTENEMIA, FAMILIAL	0.0111111	0.41684569686192796
ACROMIAL DIMPLES	0.0111111	0.41684569686192796
PRENATAL BOWING	0.0111111	0.41684569686192796
SHORT SYNDROME	0.0111111	0.41684569686192796
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.41684569686192796
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.41684569686192796
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.41684569686192796
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.41684569686192796
HYPOPLASMINOGENEMIA	0.0111111	0.41684569686192796
PYCNODYSOSTOSIS	0.0111111	0.41684569686192796
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.41684569686192796
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.41684569686192796
DERMAL RIDGES, PATTERNLESS	0.0111111	0.41684569686192796
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.41684569686192796
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.41684569686192796
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	0.41684569686192796
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	0.41684569686192796
131600 EPIDERMOID CYSTS	0.0111111	0.41684569686192796
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.41684569686192796
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.41684569686192796
PARANA HARD-SKIN SYNDROME	0.0111111	0.41684569686192796
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	0.41684569686192796
KYRLE DISEASE	0.0111111	0.41684569686192796
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.41684569686192796
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.41684569686192796
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.41684569686192796
LENTIGINES	0.0111111	0.41684569686192796
PSEUDOATROPHODERMA COLLI	0.0111111	0.41684569686192796
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.41684569686192796
LICHEN PLANUS, FAMILIAL	0.0111111	0.41684569686192796
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.41684569686192796
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.41684569686192796
TRICHILEMMAL CYST 1	0.0111111	0.41684569686192796
SAY SYNDROME	0.0111111	0.41684569686192796
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.41684569686192796
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.41684569686192796
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.41684569686192796
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.41684569686192796
SYRINGOMAS, MULTIPLE	0.0111111	0.41684569686192796
TRIOPIA	0.0111111	0.41684569686192796
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.41684569686192796
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.41684569686192796
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.41684569686192796
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.41684569686192796
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.41684569686192796
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.41684569686192796
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.41684569686192796
PILONIDAL SINUS	0.0111111	0.41684569686192796
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.41684569686192796
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.41684569686192796
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.41684569686192796
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.41684569686192796
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	0.41684569686192796
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.41684569686192796
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011084304	0.41584041410026507
PENTASOMY X	0.011071853999999999	0.4153733380298552
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.4153733380298552
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.011067718999999998	0.4152182087486387
MALAN OVERGROWTH SYNDROME	0.011067718999999998	0.4152182087486387
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.4152182087486387
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.011035772	0.41401968029712194
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.011032583	0.41390004129402663
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.011022871	0.41353568444295674
ADAMS-OLIVER SYNDROME 2; AOS2	0.011022871	0.41353568444295674
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.010993733	0.41244253885744653
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.010993733	0.41244253885744653
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.010993733	0.41244253885744653
MENTAL RETARDATION, X-LINKED 101; MRX101	0.010993733	0.41244253885744653
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0109456	0.41063677399824666
SHWACHMAN-DIAMOND SYNDROME	0.010941052	0.4104661505469837
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010941052	0.4104661505469837
COFFIN-SIRIS SYNDROME 8; CSS8	0.010936916999999999	0.4103110212657672
EMANUEL SYNDROME	0.010864691000000001	0.4076013797989863
DISTAL TRISOMY 5Q	0.01083256	0.4063959483758265
2Q23.1 MICRODUPLICATION SYNDROME	0.010801964	0.4052481042432755
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010766352	0.4039120791011521
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010766352	0.4039120791011521
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.010615653	0.3982584327770802
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.010606877	0.3979291910426291
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.010595521	0.3975031576405749
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01053875	0.39537332827565613
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.01053875	0.39537332827565613
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.010526299999999999	0.3949062522052463
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.3949062522052463
FACIOCARDIORENAL SYNDROME	0.010526299999999999	0.3949062522052463
SUMMITT SYNDROME	0.010526299999999999	0.3949062522052463
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.010526299999999999	0.3949062522052463
CRANIOFRONTONASAL DYSPLASIA	0.010526299999999999	0.3949062522052463
FAMILIAL LAMBDOID SYNOSTOSIS	0.010526299999999999	0.3949062522052463
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.010526299999999999	0.3949062522052463
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.010526299999999999	0.3949062522052463
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.010526299999999999	0.3949062522052463
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.010526299999999999	0.3949062522052463
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.010526299999999999	0.3949062522052463
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.010526299999999999	0.3949062522052463
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.010526299999999999	0.3949062522052463
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	0.3949062522052463
FACIOCARDIORENAL SYNDROME	0.010526299999999999	0.3949062522052463
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010520933	0.3947049030269419
CHROMOSOME 2Q37 DELETION SYNDROME	0.010520933	0.3947049030269419
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.010520933	0.3947049030269419
CLASSIC PHENYLKETONURIA	0.010520933	0.3947049030269419
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.010520933	0.3947049030269419
NETHERTON SYNDROME	0.010520933	0.3947049030269419
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.010520933	0.3947049030269419
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.010487029	0.3934329554694177
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.010481452	0.3932237278995642
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.010477317	0.39306859861834786
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.010452314	0.392130582314054
KAGAMI-OGATA SYNDROME	0.010451871000000001	0.39211396265950055
INFANTILE SIALIC ACID STORAGE DISEASE	0.010451871000000001	0.39211396265950055
TYSHCHENKO SYNDROME	0.010347514	0.3881988897695598
GAUCHER DISEASE, PERINATAL LETHAL	0.010343379	0.3880437604883433
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.010323272	0.3872894232555938
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.010248342	0.38447833811858095
ATAXIA-PANCYTOPENIA SYNDROME	0.01023335	0.38391589599427695
48,XXYY SYNDROME	0.010190893	0.3823230728038037
COFFIN-SIRIS SYNDROME 4; CSS4	0.010178591	0.38186154912362846
COFFIN-SIRIS SYNDROME 3; CSS3	0.010178591	0.38186154912362846
KABUKI SYNDROME 1	0.010178591	0.38186154912362846
LUSCAN-LUMISH SYNDROME; LLS	0.010178591	0.38186154912362846
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.010178591	0.38186154912362846
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.010178591	0.38186154912362846
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010145111	0.38060550841380336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.010145111	0.38060550841380336
JOUBERT SYNDROME 10	0.010074234	0.3779464762336877
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010074234	0.3779464762336877
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.010074234	0.3779464762336877
DISTAL MONOSOMY 15Q	0.010061333	0.37746248037952246
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.010054102	0.3771912010971824
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.010049967	0.377036071815966
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.009979514	0.3743929464835494
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.009975379	0.37423781720233296
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.009975379	0.37423781720233296
PHENYLKETONURIA	0.009975379	0.37423781720233296
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.009975379	0.37423781720233296
15Q26 OVERGROWTH SYNDROME	0.00994561	0.3731209989260253
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00994561	0.3731209989260253
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00994561	0.3731209989260253
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.009935898	0.37275664207495535
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.009935898	0.37275664207495535
STUVE-WIEDEMANN SYNDROME	0.009935898	0.37275664207495535
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.009935898	0.37275664207495535
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.009935898	0.37275664207495535
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009910452	0.371802006116108
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	0.371802006116108
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.009910452	0.371802006116108
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009903153	0.371528175735552
611961 STEVENSON-CAREY SYNDROME	0.009903153	0.371528175735552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009857371	0.3698106113455517
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3678388750377179
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377179
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3678388750377179
BIOTINIDASE DEFICIENCY	0.009804814	0.3678388750377179
KRABBE DISEASE	0.009804814	0.3678388750377179
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3678388750377179
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.3678388750377179
KNIEST-LIKE DYSPLASIA, LETHAL	0.00980196	0.36773180394495086
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00980196	0.36773180394495086
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00980196	0.36773180394495086
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00980196	0.36773180394495086
INTERMEDIATE NEMALINE MYOPATHY	0.00980196	0.36773180394495086
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00980196	0.36773180394495086
RESTRICTIVE DERMOPATHY, LETHAL	0.00980196	0.36773180394495086
GMS SYNDROME	0.00980196	0.36773180394495086
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565014
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565014
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009637172	0.36154959258023595
COHEN SYNDROME	0.009633983	0.36142995357714064
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.009633983	0.36142995357714064
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.009633983	0.36142995357714064
CENTRAL BILATERAL MACROGYRIA	0.009633983	0.36142995357714064
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009633983	0.36142995357714064
22Q11.2 MICRODUPLICATION SYNDROME	0.009633983	0.36142995357714064
ARGININEMIA	0.009633983	0.36142995357714064
ISOLATED GLYCEROL KINASE DEFICIENCY	0.009633983	0.36142995357714064
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.009633037	0.36139446329901953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.009633037	0.36139446329901953
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.009626741999999999	0.36115829913329817
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.009626741999999999	0.36115829913329817
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.009624271	0.36106559672607075
WITTEVEEN-KOLK SYNDROME	0.009624271	0.36106559672607075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.009624271	0.36106559672607075
TARP SYNDROME	0.009624271	0.36106559672607075
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.009624271	0.36106559672607075
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00952868	0.35747939040907883
FGFR2-RELATED BENT BONE DYSPLASIA	0.00952868	0.35747939040907883
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00952868	0.35747939040907883
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00952868	0.35747939040907883
YUNIS-VARON SYNDROME	0.009519913999999999	0.35715052383612994
SHPRINTZEN-GOLDBERG SYNDROME	0.009518249999999999	0.35708809696214106
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.009515779	0.3569953945549135
SECKEL SYNDROME 1; SCKL1	0.009515779	0.3569953945549135
FRYNS SYNDROME; FRNS	0.009515779	0.3569953945549135
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.009515779	0.3569953945549135
LOWRY-MACLEAN SYNDROME	0.009515779	0.3569953945549135
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.009508548	0.35672411527257347
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3560407585960662
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009490333	0.3560407585960662
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.3560407585960662
GALLOWAY-MOWAT SYNDROME	0.009490333	0.3560407585960662
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3560407585960662
CONGENITAL TOXOPLASMOSIS	0.009490333	0.3560407585960662
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009466091000000001	0.3551312920821003
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.3539258606589405
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00943396	0.3539258606589405
IGE RESPONSIVENESS, ATOPIC	0.00943396	0.3539258606589405
WISKOTT-ALDRICH SYNDROME	0.00943396	0.3539258606589405
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.3539258606589405
CASPASE 8 DEFICIENCY	0.00943396	0.3539258606589405
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00943396	0.3539258606589405
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.3539258606589405
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.3539258606589405
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.3539258606589405
BAZEX SYNDROME; BZX	0.00943396	0.3539258606589405
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00943396	0.3539258606589405
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00943396	0.3539258606589405
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.3539258606589405
DERMATITIS HERPETIFORMIS	0.00943396	0.3539258606589405
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00943396	0.3539258606589405
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.3539258606589405
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00943396	0.3539258606589405
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.3539258606589405
IMMUNODEFICIENCY 55; IMD55	0.00943396	0.3539258606589405
BULLOUS PEMPHIGOID	0.00943396	0.3539258606589405
ELASTODERMA	0.00943396	0.3539258606589405
CHRONIC GRANULOMATOUS DISEASE	0.00943396	0.3539258606589405
BLAU SYNDROME	0.00943396	0.3539258606589405
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.3539258606589405
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00943396	0.3539258606589405
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00943396	0.3539258606589405
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00943396	0.3539258606589405
MYCOSIS FUNGOIDES	0.00943396	0.3539258606589405
PITYRIASIS RUBRA PILARIS	0.00943396	0.3539258606589405
DERMATITIS, ATOPIC	0.00943396	0.3539258606589405
ACRAL PEELING SKIN SYNDROME	0.00943396	0.3539258606589405
CRANIO-OSTEOARTHROPATHY	0.00943396	0.3539258606589405
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00943396	0.3539258606589405
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00943396	0.3539258606589405
IMMUNODEFICIENCY 50; IMD50	0.00943396	0.3539258606589405
NEMALINE MYOPATHY 10	0.009364898	0.35133492029149904
TEMPLE SYNDROME	0.009364898	0.35133492029149904
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.35133492029149904
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	0.35133492029149904
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.35133492029149904
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	0.35133492029149904
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.009357599	0.3510610899109431
PERIPHERAL HYPOTHYROIDISM	0.009352022	0.3508518623410896
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.009352022	0.3508518623410896
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.009352022	0.3508518623410896
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.009352022	0.3508518623410896
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009311817	0.3493435255209428
HOLMES-GANG SYNDROME	0.009286804000000001	0.34840513405514667
PAINE SYNDROME	0.00925926	0.34737178921310896
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310896
GAUCHER DISEASE TYPE 3	0.00925926	0.34737178921310896
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34737178921310896
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310896
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310896
GAUCHER DISEASE TYPE 2	0.00925926	0.34737178921310896
MERRF	0.00925926	0.34737178921310896
HYDROXYLYSINURIA	0.00925926	0.34737178921310896
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310896
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310896
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310896
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310896
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
CARNOSINEMIA	0.00925926	0.34737178921310896
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.009217053	0.3457883450601942
WAISMAN SYNDROME; WSMN	0.009183573	0.34453230435036913
ANGELMAN SYNDROME	0.009116441000000001	0.3420137701528788
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.009116441000000001	0.3420137701528788
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.009092564000000001	0.3411179970337482
GERMAN SYNDROME	0.009092564000000001	0.3411179970337482
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.009092564000000001	0.3411179970337482
ISOLATED CEREBELLAR AGENESIS	0.009088429	0.3409628677525317
SIALIDOSIS TYPE 1	0.009088429	0.3409628677525317
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009088429	0.3409628677525317
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.009088429	0.3409628677525317
NEUROFIBROMATOSIS TYPE 1	0.009088429	0.3409628677525317
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009088429	0.3409628677525317
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.009088429	0.3409628677525317
NEURONAL CEROID LIPOFUSCINOSIS	0.009088429	0.3409628677525317
CONGENITAL RUBELLA SYNDROME	0.009088429	0.3409628677525317
MUSCLE-EYE-BRAIN DISEASE	0.009088429	0.3409628677525317
MICROPHTHALMIA, LENZ TYPE	0.009088429	0.3409628677525317
FOUNTAIN SYNDROME	0.009088429	0.3409628677525317
TAKAYASU ARTERITIS	0.009088429	0.3409628677525317
WHIM SYNDROME	0.009088429	0.3409628677525317
WORSTER-DROUGHT SYNDROME	0.009088429	0.3409628677525317
METACHROMATIC LEUKODYSTROPHY	0.009088429	0.3409628677525317
CEREBROTENDINOUS XANTHOMATOSIS	0.009088429	0.3409628677525317
COFFIN-LOWRY SYNDROME	0.009088429	0.3409628677525317
STURGE-WEBER SYNDROME	0.009088429	0.3409628677525317
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.009088429	0.3409628677525317
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.009088429	0.3409628677525317
WARSAW BREAKAGE SYNDROME; WABS	0.009082852	0.34075364018267823
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009082852	0.34075364018267823
DESBUQUOIS DYSPLASIA 2; DBQD2	0.009082852	0.34075364018267823
PEROXISOME BIOGENESIS DISORDER 3B	0.009082852	0.34075364018267823
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.009081187999999999	0.34069121330868923
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.009078717	0.3405985109014618
COHEN SYNDROME	0.009078717	0.3405985109014618
COFFIN-LOWRY SYNDROME; CLS	0.009078717	0.3405985109014618
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.009078717	0.3405985109014618
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.008979601	0.336880060154896
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00897436	0.3366834380115211
OROFACIAL CLEFT 15	0.00897436	0.3366834380115211
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00897436	0.3366834380115211
MOSAIC TRISOMY 1	0.00897436	0.3366834380115211
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00897436	0.3366834380115211
TEEBI-SHALTOUT SYNDROME; TBSH	0.00897436	0.3366834380115211
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00897436	0.3366834380115211
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	0.33572880205267375
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.33572880205267375
CINCA SYNDROME	0.008948914	0.33572880205267375
ZELLWEGER SYNDROME	0.008944779	0.3355736727714573
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.3355736727714573
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.008924672	0.3348193355387078
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.008895832999999999	0.3337374072821174
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.008895832999999999	0.3337374072821174
8P23.1 MICRODELETION SYNDROME	0.008895832999999999	0.3337374072821174
MAN1B1-CDG	0.008895832999999999	0.3337374072821174
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.008849742	0.3320082504016949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.008845607	0.33185312112047843
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.008806468	0.3303847765164807
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00872859	0.3274630937685788
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.008675634	0.3254763885168017
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008675634	0.3254763885168017
RABSON-MENDENHALL SYNDROME	0.008675634	0.3254763885168017
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.008671499	0.32532125923558525
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.008671499	0.32532125923558525
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.008671499	0.32532125923558525
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.008671499	0.32532125923558525
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.008671499	0.32532125923558525
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.008671499	0.32532125923558525
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.008671499	0.32532125923558525
TOWNES-BROCKS SYNDROME 1; TBS1	0.008665204	0.32508509506986394
KBG SYNDROME	0.008662733	0.32499239266263646
KBG SYNDROME	0.008662733	0.32499239266263646
HEREDITARY HYPEREKPLEXIA	0.008661069	0.3249299657886476
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.008642154	0.32422034780697667
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.008642154	0.32422034780697667
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.008642154	0.32422034780697667
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.008638019	0.3240652185257602
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.008638019	0.3240652185257602
MOWAT-WILSON SYNDROME; MOWS	0.008570887000000001	0.3215466843282699
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.008549342	0.32073839887148425
TRISOMY XQ28	0.00854701	0.32065091120913924
PENDRED SYNDROME	0.00854701	0.32065091120913924
NEURALGIC AMYOTROPHY	0.00854701	0.32065091120913924
PRIMARY PROGRESSIVE FREEZING GAIT	0.00854701	0.32065091120913924
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.32065091120913924
SHORT SYNDROME	0.00854701	0.32065091120913924
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00854701	0.32065091120913924
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.32065091120913924
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00854701	0.32065091120913924
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00854701	0.32065091120913924
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00854701	0.32065091120913924
VON HIPPEL-LINDAU DISEASE	0.00854701	0.32065091120913924
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00854701	0.32065091120913924
HISTIDINEMIA	0.00854701	0.32065091120913924
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.32065091120913924
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.32065091120913924
ALOPECIA ANTIBODY DEFICIENCY	0.00854701	0.32065091120913924
BARDET-BIEDL SYNDROME	0.00854701	0.32065091120913924
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00854701	0.32065091120913924
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.32065091120913924
ALBINISM-DEAFNESS SYNDROME	0.00854701	0.32065091120913924
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00854701	0.32065091120913924
ALZHEIMER DISEASE 10	0.00854701	0.32065091120913924
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00854701	0.32065091120913924
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00854701	0.32065091120913924
CAMURATI-ENGELMANN DISEASE	0.00854701	0.32065091120913924
HISTIDINEMIA	0.00854701	0.32065091120913924
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00854701	0.32065091120913924
RECESSIVE X-LINKED ICHTHYOSIS	0.00854701	0.32065091120913924
GOLDENHAR SYNDROME	0.00854701	0.32065091120913924
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00854701	0.32065091120913924
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.32065091120913924
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00854701	0.32065091120913924
BRANCHIO-OCULO-FACIAL SYNDROME	0.00854701	0.32065091120913924
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.008537298	0.3202865543580693
HOLOPROSENCEPHALY	0.008504553	0.31905808801866603
KLEEFSTRA SYNDROME	0.008504553	0.31905808801866603
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.008504553	0.31905808801866603
48,XXXY SYNDROME	0.008504553	0.31905808801866603
49,XXXXY SYNDROME	0.008504553	0.31905808801866603
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.008458771	0.31734052362866566
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.008458771	0.31734052362866566
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008458771	0.31734052362866566
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.008458771	0.31734052362866566
MEHMO SYNDROME; MEHMO	0.008458771	0.31734052362866566
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.008458771	0.31734052362866566
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008458771	0.31734052362866566
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.008458771	0.31734052362866566
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00844085	0.3166681967003271
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3152617162280648
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.3152617162280648
OMPHALOCELE	0.00840336	0.3152617162280648
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.3152617162280648
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.3152617162280648
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.3152617162280648
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.3152617162280648
VACTERL/VATER ASSOCIATION	0.00840336	0.3152617162280648
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3152617162280648
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280648
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3152617162280648
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.3152617162280648
EBSTEIN MALFORMATION	0.00840336	0.3152617162280648
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3152617162280648
RETINOPATHY OF PREMATURITY	0.00840336	0.3152617162280648
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.3152617162280648
CONGENITAL ANALBUMINEMIA	0.00840336	0.3152617162280648
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3152617162280648
SCHISIS ASSOCIATION	0.00840336	0.3152617162280648
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.3152617162280648
FATCO SYNDROME	0.00840336	0.3152617162280648
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3152617162280648
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3152617162280648
HYDROLETHALUS	0.00840336	0.3152617162280648
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280648
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3152617162280648
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.3152617162280648
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3152617162280648
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3152617162280648
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3152617162280648
HEC SYNDROME	0.00840336	0.3152617162280648
PEMPHIGOID GESTATIONIS	0.00840336	0.3152617162280648
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3152617162280648
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3152617162280648
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3152617162280648
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3152617162280648
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3152617162280648
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3152617162280648
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3152617162280648
TEMPLE SYNDROME	0.00840336	0.3152617162280648
THYROID ECTOPIA	0.008390484	0.3147786582776554
CONGENITAL HYPOTHYROIDISM	0.008390484	0.3147786582776554
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.008390484	0.3147786582776554
FAMILIAL THYROID DYSHORMONOGENESIS	0.008390484	0.3147786582776554
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.008390484	0.3147786582776554
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.008390484	0.3147786582776554
THYROID HEMIAGENESIS	0.008390484	0.3147786582776554
PERMANENT CONGENITAL HYPOTHYROIDISM	0.008390484	0.3147786582776554
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.008379118	0.31435224971409886
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.008379118	0.31435224971409886
SLC39A8-CDG	0.008350279	0.31327032145750855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.008154903	0.3059405660894445
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.008154903	0.3059405660894445
GONADOBLASTOMA	0.00813008	0.3050093026921928
OVARIAN DYSGENESIS 2; ODG2	0.00813008	0.3050093026921928
CARNEY COMPLEX, TYPE 1; CNC1	0.00813008	0.3050093026921928
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00813008	0.3050093026921928
XYLT1-CDG	0.00813008	0.3050093026921928
OVARIAN HYPERSTIMULATION SYNDROME	0.00813008	0.3050093026921928
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00813008	0.3050093026921928
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00813008	0.3050093026921928
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.00813008	0.3050093026921928
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.00813008	0.3050093026921928
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00813008	0.3050093026921928
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00813008	0.3050093026921928
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.00813008	0.3050093026921928
INSULIN-RESISTANCE SYNDROME TYPE B	0.00813008	0.3050093026921928
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00813008	0.3050093026921928
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00813008	0.3050093026921928
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00813008	0.3050093026921928
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00813008	0.3050093026921928
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00813008	0.3050093026921928
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00813008	0.3050093026921928
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00813008	0.3050093026921928
OVARIAN FIBROTHECOMA	0.00813008	0.3050093026921928
CRANIORHINY	0.00813008	0.3050093026921928
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00813008	0.3050093026921928
ACHALASIA-MICROCEPHALY SYNDROME	0.00813008	0.3050093026921928
CARNEY COMPLEX	0.00813008	0.3050093026921928
POLYCYSTIC OVARY SYNDROME 1	0.00813008	0.3050093026921928
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00813008	0.3050093026921928
46,XY SEX REVERSAL 6; SRXY6	0.00813008	0.3050093026921928
ACANTHOSIS NIGRICANS-INSULIN RESISTANCE-MUSCLE CRAMPS-ACRAL ENLARGEMENT SYNDROME	0.00813008	0.3050093026921928
FRONTOMETAPHYSEAL DYSPLASIA	0.00813008	0.3050093026921928
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00813008	0.3050093026921928
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00813008	0.3050093026921928
PSEUDOAMINOPTERIN SYNDROME	0.008121314	0.30468043611924395
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008121314	0.30468043611924395
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.008121314	0.30468043611924395
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.008121314	0.30468043611924395
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.008121314	0.30468043611924395
MEIER-GORLIN SYNDROME 6; MGORS6	0.008119649999999999	0.304618009245255
X-LINKED EHLERS-DANLOS SYNDROME	0.008119649999999999	0.304618009245255
FILIPPI SYNDROME; FLPIS	0.008117179	0.30452530683802753
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.008117179	0.30452530683802753
POTOCKI-SHAFFER SYNDROME	0.008117179	0.30452530683802753
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.007963134	0.29874613147527357
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.007963134	0.29874613147527357
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.007917352	0.29702856708527325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.007917352	0.29702856708527325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.007917352	0.29702856708527325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007917352	0.29702856708527325
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007917352	0.29702856708527325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007917352	0.29702856708527325
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.007917352	0.29702856708527325
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.007913217	0.29687343780405673
MENTAL RETARDATION, X-LINKED 1	0.007913217	0.29687343780405673
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007884069	0.2957799170570442
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007884069	0.2957799170570442
14Q12 MICRODELETION SYNDROME	0.007884069	0.2957799170570442
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00784493	0.29431157245304645
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00784493	0.29431157245304645
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00784493	0.29431157245304645
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00784493	0.29431157245304645
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00784493	0.29431157245304645
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007720611	0.28964760217214014
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.007720611	0.28964760217214014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.007609349000000001	0.28547348026483566
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
1Q44 MICRODELETION SYNDROME	0.007587804	0.28466519480804997
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683356
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683356
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.007581001	0.28440997243801
CZEIZEL-LOSONCI SYNDROME	0.00757576	0.284213350294635
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00757576	0.284213350294635
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00757576	0.284213350294635
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00757576	0.284213350294635
BASAN SYNDROME	0.00757576	0.284213350294635
268650 RUDIGER SYNDROME	0.00757576	0.284213350294635
MONOSOMY 22	0.00757576	0.284213350294635
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.00757576	0.284213350294635
POSTAXIAL OLIGODACTYLY, TETRAMELIC	0.00757576	0.284213350294635
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00757576	0.284213350294635
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00757576	0.284213350294635
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00757576	0.284213350294635
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.00757576	0.284213350294635
CRANIOECTODERMAL DYSPLASIA 1	0.00757576	0.284213350294635
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00757576	0.284213350294635
TETRAGAMETIC CHIMERISM	0.00757576	0.284213350294635
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00757576	0.284213350294635
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00757576	0.284213350294635
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00757576	0.284213350294635
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00757576	0.284213350294635
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.007497233000000001	0.28126731956523143
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.007497233000000001	0.28126731956523143
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.007497233000000001	0.28126731956523143
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.007497233000000001	0.28126731956523143
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.007497233000000001	0.28126731956523143
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.007497233000000001	0.28126731956523143
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.007497233	0.28126731956523143
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.007497233	0.28126731956523143
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007497233	0.28126731956523143
WILSON-TURNER SYNDROME	0.007497233	0.28126731956523143
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007497233	0.28126731956523143
KOOLEN-DE VRIES SYNDROME	0.007497233	0.28126731956523143
NK-CELL ENTEROPATHY	0.00741758	0.27827904565066464
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.007371798000000001	0.2765614812606643
HEART AND BRAIN MALFORMATION SYNDROME	0.0072932610000000005	0.2736150753697583
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0072313510000000004	0.2712924505087885
COHEN-GIBSON SYNDROME; COGIS	0.007179191999999999	0.2693356456287477
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
AMISH LETHAL MICROCEPHALY	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.007039582	0.2640980158946175
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007018541	0.2633086385775497
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.006955814	0.2609553630218389
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.006955814	0.2609553630218389
FRIED SYNDROME	0.006955814	0.2609553630218389
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.006955814	0.2609553630218389
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.006955814	0.2609553630218389
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.006955814	0.2609553630218389
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.006955814	0.2609553630218389
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.006955814	0.2609553630218389
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.006955814	0.2609553630218389
COG8-CDG	0.0069516790000000005	0.2608002337406225
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0069516790000000005	0.2608002337406225
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0069516790000000005	0.2608002337406225
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.0069516790000000005	0.2608002337406225
MENTAL RETARDATION, X-LINKED 100	0.0069516790000000005	0.2608002337406225
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0069516790000000005	0.2608002337406225
MENTAL RETARDATION, X-LINKED 14	0.0069516790000000005	0.2608002337406225
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006943611000000001	0.2604975534405368
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.006943611000000001	0.2604975534405368
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.006943611000000001	0.2604975534405368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006943611000000001	0.2604975534405368
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006943611000000001	0.2604975534405368
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006943611000000001	0.2604975534405368
MONOSOMY 9Q22.3	0.006759072999999999	0.25357439810870586
DIGEORGE SYNDROME; DGS	0.006759072999999999	0.25357439810870586
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.006759072999999999	0.25357439810870586
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.006747707	0.2531479895451494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.006747707	0.2531479895451494
MARSHALL-SMITH SYNDROME; MRSHSS	0.006633637999999999	0.24886855980413872
OCULODENTODIGITAL DYSPLASIA	0.006501258999999999	0.24390220935234858
TRIGEMINAL NEURALGIA	0.00641026	0.24048827719723
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00641026	0.24048827719723
SOTOS SYNDROME 3	0.00641026	0.24048827719723
AL-RAQAD SYNDROME; ARS	0.006402192000000001	0.24018559689714436
HADZISELIMOVIC SYNDROME	0.006402192	0.2401855968971443
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006402192	0.2401855968971443
ADENYLOSUCCINATE LYASE DEFICIENCY	0.006398057	0.2400304676159279
BOHRING-OPITZ SYNDROME	0.006331722999999999	0.237541871306324
GENITOPATELLAR SYNDROME	0.006331722999999999	0.237541871306324
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.006322011	0.2371775144552541
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.006322011	0.2371775144552541
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.006269813	0.2352192464453542
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.006269813	0.2352192464453542
CHROMOSOME 1P35 DELETION SYNDROME	0.006269813	0.2352192464453542
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0062176539999999995	0.2332624415653134
DE BARSY SYNDROME	0.0062176539999999995	0.2332624415653134
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0062176539999999995	0.2332624415653134
LATERAL MENINGOCELE SYNDROME	0.0062176539999999995	0.2332624415653134
ICF SYNDROME	0.0062176539999999995	0.2332624415653134
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0062176539999999995	0.2332624415653134
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.006213518999999999	0.2331073122840969
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.006206288	0.2328360330017569
PGM3-CDG	0.006073909	0.22786968254996678
RUBINSTEIN-TAYBI SYNDROME	0.006057003	0.22723543451411546
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005982073000000001	0.22442434937710257
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.005982073	0.22442434937710254
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005982073	0.22442434937710254
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005982073	0.22442434937710254
SSR4-CDG	0.005894661000000001	0.22114498765287227
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.005894661000000001	0.22114498765287227
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.005894661000000001	0.22114498765287227
CODAS SYNDROME	0.005894661000000001	0.22114498765287227
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.005894660999999999	0.22114498765287224
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.005894660999999999	0.22114498765287224
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005894660999999999	0.22114498765287224
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.005803324	0.21771837503897465
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005803324	0.21771837503897465
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005799189	0.2175632457577582
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005799189	0.2175632457577582
WOLFRAM SYNDROME	0.005799189	0.2175632457577582
3Q29 MICRODELETION SYNDROME	0.005790304	0.21722991476293155
OKAMOTO SYNDROME	0.005790304	0.21722991476293155
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.005790304	0.21722991476293155
SWEENEY-COX SYNDROME; SWCOS	0.005790304	0.21722991476293155
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.005786169	0.21707478548171508
WIEDEMANN-STEINER SYNDROME	0.005786169	0.21707478548171508
CRANIOFRONTONASAL SYNDROME; CFNS	0.005780591999999999	0.21686555791186163
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.005780591999999999	0.21686555791186163
ACROCALLOSAL SYNDROME; ACLS	0.005776457	0.21671042863064516
CHROMOSOME 18Q DELETION SYNDROME	0.005776457	0.21671042863064516
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.005776456999999999	0.21671042863064513
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005728394	0.21490728990196176
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.005724259000000001	0.2147521606207453
3MC SYNDROME	0.005672099999999999	0.21279535574070446
SCARF SYNDROME	0.005672099999999999	0.21279535574070446
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.005672099999999999	0.21279535574070446
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.005672099999999999	0.21279535574070446
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.005672099999999999	0.21279535574070446
GAPO SYNDROME	0.005672099999999999	0.21279535574070446
CRANIOFACIAL DYSSYNOSTOSIS	0.005672099999999999	0.21279535574070446
HYPERTELORISM, TEEBI TYPE	0.005672099999999999	0.21279535574070446
ACROOSTEOLYSIS DOMINANT TYPE	0.005672099999999999	0.21279535574070446
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.005672099999999999	0.21279535574070446
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.005672099999999999	0.21279535574070446
HOLOPROSENCEPHALY 2; HPE2	0.005619941	0.21083855086066366
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.005619941	0.21083855086066366
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.005619941	0.21083855086066366
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005619941	0.21083855086066366
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.005619941	0.21083855086066366
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.005619941	0.21083855086066366
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.005619941	0.21083855086066366
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.005619941	0.21083855086066366
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.005545011000000001	0.20802746572365077
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005545011000000001	0.20802746572365077
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005545011000000001	0.20802746572365077
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.005545011000000001	0.20802746572365077
RAYNAUD-CLAES SYNDROME; MRXSRC	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005545011000000001	0.20802746572365077
AICARDI-GOUTIERES SYNDROME 7	0.005545011000000001	0.20802746572365077
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005545011000000001	0.20802746572365077
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.005545011000000001	0.20802746572365077
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005545011000000001	0.20802746572365077
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005545011000000001	0.20802746572365077
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005545011000000001	0.20802746572365077
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005545011000000001	0.20802746572365077
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.005545011000000001	0.20802746572365077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005545011000000001	0.20802746572365077
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005545011000000001	0.20802746572365077
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005545011000000001	0.20802746572365077
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005545011000000001	0.20802746572365077
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005545011000000001	0.20802746572365077
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.005545011000000001	0.20802746572365077
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.005545011000000001	0.20802746572365077
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00553249	0.20755772600657432
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00553249	0.20755772600657432
NATIVE AMERICAN MYOPATHY	0.00553249	0.20755772600657432
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.005515584	0.20692347797072294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005436519000000001	0.20395726355249363
DONNAI-BARROW SYNDROME	0.005360472999999999	0.20110431039181983
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.20110431039181983
HYPEREKPLEXIA 4; HKPX4	0.005360472999999999	0.20110431039181983
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.20110431039181983
MUCOPOLYSACCHARIDOSIS TYPE 2	0.005360472999999999	0.20110431039181983
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005353242	0.20083303110947978
TENORIO SYNDROME; TNORS	0.0053491070000000005	0.20067790182826334
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0053491070000000005	0.20067790182826334
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0053491070000000005	0.20067790182826334
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00525777	0.19725128921436572
PARKINSON DISEASE, LATE-ONSET; PD	0.00525777	0.19725128921436572
WOUND BOTULISM	0.00525777	0.19725128921436572
INFANT BOTULISM	0.00525777	0.19725128921436572
FOODBORNE BOTULISM	0.00525777	0.19725128921436572
BOTULISM	0.00525777	0.19725128921436572
MULTIPLE SYSTEM ATROPHY	0.00525777	0.19725128921436572
MEIER-GORLIN SYNDROME 3; MGORS3	0.005244749999999999	0.19676282893832261
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.005244749999999999	0.19676282893832261
MEIER-GORLIN SYNDROME 5; MGORS5	0.005244749999999999	0.19676282893832261
MEIER-GORLIN SYNDROME 1; MGORS1	0.005244749999999999	0.19676282893832261
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.005244749999999999	0.19676282893832261
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.005235037999999999	0.1963984720872527
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.005235037999999999	0.1963984720872527
ARTERIAL TORTUOSITY SYNDROME	0.005235037999999999	0.1963984720872527
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.005235037999999999	0.1963984720872527
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005078522	0.19052659431727123
NIEMANN-PICK DISEASE, TYPE A	0.005078522	0.19052659431727123
HYPOPHOSPHATASIA, INFANTILE	0.005074387	0.19037146503605473
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005003592000000001	0.18771550918025834
JOUBERT SYNDROME 24	0.005003592000000001	0.18771550918025834
YOU-HOOVER-FONG SYNDROME; YHFS	0.005003592000000001	0.18771550918025834
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005003592000000001	0.18771550918025834
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005003592000000001	0.18771550918025834
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005003592	0.18771550918025828
OPTIC ATROPHY 11; OPA11	0.005003592	0.18771550918025828
MUCOLIPIDOSIS IV; ML4	0.005003592	0.18771550918025828
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.005003592	0.18771550918025828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0049994570000000006	0.18756037989904184
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0049994570000000006	0.18756037989904184
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0049994570000000006	0.18756037989904184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0049994570000000006	0.18756037989904184
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0049994570000000006	0.18756037989904184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0049994570000000006	0.18756037989904184
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00497003	0.18645639214611406
KAPUR-TORIELLO SYNDROME	0.00497003	0.18645639214611406
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.004933123	0.18507178358943802
WEBB-DATTANI SYNDROME; WEDAS	0.004933123	0.18507178358943802
1Q21.1 MICRODUPLICATION SYNDROME	0.004933123	0.18507178358943802
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004933123	0.18507178358943802
HEREDITARY FOLATE MALABSORPTION	0.004933123	0.18507178358943802
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.004933123	0.18507178358943802
MIRAGE SYNDROME; MIRAGE	0.004933123	0.18507178358943802
SEVERE CANAVAN DISEASE	0.004933122999999999	0.185071783589438
CANAVAN DISEASE	0.004933122999999999	0.185071783589438
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0048951	0.18364530700910114
ABLEPHARON MACROSTOMIA SYNDROME	0.004819054	0.18079235384842735
FANCONI ANEMIA	0.004819054	0.18079235384842735
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.18079235384842735
PETERS PLUS SYNDROME	0.004819054	0.18079235384842735
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004819054	0.18079235384842735
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.18079235384842735
XP22.13P22.2 DUPLICATION SYNDROME	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.18063722456721087
BRANCHIOSKELETOGENITAL SYNDROME	0.004814918999999999	0.18063722456721087
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004814918999999999	0.18063722456721087
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.18063722456721087
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.18063722456721087
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.18063722456721087
DISTAL MONOSOMY 3P	0.004814918999999999	0.18063722456721087
GAPO SYNDROME; GAPOS	0.004814918999999999	0.18063722456721087
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.004814918999999999	0.18063722456721087
MENKES DISEASE	0.004814918999999999	0.18063722456721087
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.004807688	0.18036594528487085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.004807688	0.18036594528487085
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.004807688	0.18036594528487085
PRADER-WILLI-LIKE SYNDROME	0.004658403	0.1747653467972294
NEPHROGENIC DIABETES INSIPIDUS	0.004658403	0.1747653467972294
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004658403	0.1747653467972294
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.1747653467972294
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004658403	0.1747653467972294
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004658403	0.1747653467972294
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004587897	0.17212023310885047
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473000000001	0.17195426166021652
FOIX-CHAVANY-MARIE SYNDROME	0.004583473000000001	0.17195426166021652
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473000000001	0.17195426166021652
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473000000001	0.17195426166021652
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473000000001	0.17195426166021652
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 103	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473000000001	0.17195426166021652
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004583473000000001	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004583473000000001	0.17195426166021652
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473000000001	0.17195426166021652
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004583473000000001	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473000000001	0.17195426166021652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473000000001	0.17195426166021652
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004583473	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004583473	0.17195426166021652
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004583473	0.17195426166021652
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473	0.17195426166021652
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004583473	0.17195426166021652
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004583473	0.17195426166021652
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004583473	0.17195426166021652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004583473	0.17195426166021652
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004583473	0.17195426166021652
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004583473	0.17195426166021652
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473	0.17195426166021652
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004583473	0.17195426166021652
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004583473	0.17195426166021652
LISSENCEPHALY 8; LIS8	0.004583473	0.17195426166021652
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.004532968	0.1700595084926623
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.004532968	0.1700595084926623
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.004458038000000001	0.1672484233556494
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.004458038000000001	0.1672484233556494
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.004458038000000001	0.1672484233556494
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.004458038000000001	0.1672484233556494
OCCIPITAL HORN SYNDROME	0.004391704	0.16475982704604553
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.004391704	0.16475982704604553
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.004391704	0.16475982704604553
CHOPS SYNDROME; CHOPS	0.004391704	0.16475982704604553
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004391704	0.16475982704604553
8Q12 MICRODUPLICATION SYNDROME	0.004391704	0.16475982704604553
POPOV-CHANG SYNDROME; POPCHAS	0.004391704	0.16475982704604553
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004391704	0.16475982704604553
BAKER-GORDON SYNDROME; BAGOS	0.004391704	0.16475982704604553
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004391704	0.16475982704604553
CHARGE SYNDROME	0.004391704	0.16475982704604553
ARTERIAL TORTUOSITY SYNDROME	0.004391704	0.16475982704604553
ATYPICAL RETT SYNDROME	0.004387569	0.16460469776482908
CITRULLINEMIA TYPE I	0.004387569	0.16460469776482908
SCLERODERMA	0.004387569	0.16460469776482908
FAMILIAL DYSAUTONOMIA	0.004387569	0.16460469776482908
HADDAD SYNDROME	0.004387569	0.16460469776482908
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.004387569	0.16460469776482908
MIXED CONNECTIVE TISSUE DISEASE	0.004387569	0.16460469776482908
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.004387569	0.16460469776482908
FRYNS SYNDROME	0.004387569	0.16460469776482908
FRASER SYNDROME	0.0042734999999999995	0.1603252680238184
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0042734999999999995	0.1603252680238184
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.1603252680238184
FRANK-TER HAAR SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0042734999999999995	0.1603252680238184
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0042734999999999995	0.1603252680238184
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1603252680238184
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1603252680238184
BRITTLE CORNEA SYNDROME 2; BCS2	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0042734999999999995	0.1603252680238184
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1603252680238184
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1603252680238184
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.1603252680238184
CARPENTER SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA	0.0042734999999999995	0.1603252680238184
LOEYS-DIETZ SYNDROME 3; LDS3	0.0042734999999999995	0.1603252680238184
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.1603252680238184
MESOMELIA-SYNOSTOSES SYNDROME	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0042734999999999995	0.1603252680238184
OMODYSPLASIA 1; OMOD1	0.0042734999999999995	0.1603252680238184
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0042734999999999995	0.1603252680238184
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.1603252680238184
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1B	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1603252680238184
BLADDER EXSTROPHY	0.0042734999999999995	0.1603252680238184
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.1603252680238184
FAMILIAL VISCERAL MYOPATHY	0.0042734999999999995	0.1603252680238184
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1603252680238184
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1603252680238184
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.1603252680238184
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.1603252680238184
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1603252680238184
LEPRECHAUNISM	0.0042734999999999995	0.1603252680238184
ATHYREOSIS	0.004116984	0.15445339025383692
THYROID HYPOPLASIA	0.004116984	0.15445339025383692
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004116984	0.15445339025383692
300270 ADRENOMYODYSTROPHY	0.004116984	0.15445339025383692
PROPIONIC ACIDEMIA	0.004116984	0.15445339025383692
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.15445339025383692
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262048
GITELMAN SYNDROME	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
MOWAT-WILSON SYNDROME	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.15164230511682406
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.004042054000000001	0.15164230511682406
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004042054000000001	0.15164230511682406
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.15164230511682406
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.15164230511682406
TRANSKETOLASE DEFICIENCY	0.004042054000000001	0.15164230511682406
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.15164230511682406
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.15164230511682406
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.15164230511682406
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.15164230511682406
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.004037919000000001	0.15148717583560758
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004037919000000001	0.15148717583560758
HALL-RIGGS SYNDROME	0.004037919000000001	0.15148717583560758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.004037919000000001	0.15148717583560758
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.15148717583560758
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004037919000000001	0.15148717583560758
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.15148717583560758
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004037919000000001	0.15148717583560758
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.15148717583560758
ANGELMAN SYNDROME	0.004037919000000001	0.15148717583560758
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.004037919000000001	0.15148717583560758
ISOTRETINOIN-LIKE SYNDROME	0.00384615	0.1442927412214366
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00384615	0.1442927412214366
CHRONIC GRAFT VERSUS HOST DISEASE	0.00384615	0.1442927412214366
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.1442927412214366
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.1442927412214366
MÉNÉTRIER DISEASE	0.00384615	0.1442927412214366
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.1442927412214366
STICKLER SYNDROME	0.00384615	0.1442927412214366
SANDIFER SYNDROME	0.00384615	0.1442927412214366
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.1442927412214366
ESOPHAGEAL ATRESIA	0.00384615	0.1442927412214366
CARCINOMA OF ESOPHAGUS	0.00384615	0.1442927412214366
REYNOLDS SYNDROME	0.00384615	0.1442927412214366
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.1442927412214366
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.1442927412214366
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00384615	0.1442927412214366
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.1442927412214366
ADENOCARCINOMA OF THE ESOPHAGUS	0.00384615	0.1442927412214366
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.1442927412214366
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.1442927412214366
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.1442927412214366
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.1442927412214366
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00384615	0.1442927412214366
GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.1442927412214366
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.003734851	0.14011723121657338
SALLA DISEASE	0.003734851	0.14011723121657338
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.003734851	0.14011723121657338
LEIGH SYNDROME; LS	0.003734851	0.14011723121657338
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003734851	0.14011723121657338
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.003734851	0.14011723121657338
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.003734851	0.14011723121657338
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.003734851	0.14011723121657338
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.003734851	0.14011723121657338
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.003734851	0.14011723121657338
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003734851	0.14011723121657338
SPINOCEREBELLAR ATAXIA TYPE 13	0.003734851	0.14011723121657338
ATTRV30M AMYLOIDOSIS	0.00357143	0.13398630442922801
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13398630442922801
FG SYNDROME 2; FGS2	0.00357143	0.13398630442922801
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13398630442922801
PRUNE BELLY SYNDROME	0.00357143	0.13398630442922801
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.13398630442922801
PARATHYROID CARCINOMA	0.00357143	0.13398630442922801
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13398630442922801
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.13398630442922801
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13398630442922801
TOWNES-BROCKS SYNDROME	0.00357143	0.13398630442922801
WAARDENBURG-SHAH SYNDROME	0.00357143	0.13398630442922801
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13398630442922801
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.13398630442922801
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.13398630442922801
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13398630442922801
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13398630442922801
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.13398630442922801
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13398630442922801
TYPHOID	0.00357143	0.13398630442922801
PANHYPOPITUITARISM	0.00357143	0.13398630442922801
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13398630442922801
ADIPOSIS DOLOROSA	0.00357143	0.13398630442922801
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13398630442922801
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13398630442922801
PURE AUTONOMIC FAILURE	0.00357143	0.13398630442922801
SHEEHAN SYNDROME	0.00357143	0.13398630442922801
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13398630442922801
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13398630442922801
PSEUDOMYXOMA PERITONEI	0.00357143	0.13398630442922801
PORPHYRIA VARIEGATA	0.00357143	0.13398630442922801
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.13398630442922801
CAP POLYPOSIS	0.00357143	0.13398630442922801
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13398630442922801
UROFACIAL SYNDROME 2	0.00357143	0.13398630442922801
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13398630442922801
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13398630442922801
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13398630442922801
GRFOMA	0.00357143	0.13398630442922801
SOMATOSTATINOMA	0.00357143	0.13398630442922801
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13398630442922801
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13398630442922801
PPOMA	0.00357143	0.13398630442922801
GLUCAGONOMA	0.00357143	0.13398630442922801
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13398630442922801
UROFACIAL SYNDROME	0.00357143	0.13398630442922801
VISCERAL MYOPATHY; VSCM	0.00357143	0.13398630442922801
INHALATIONAL BOTULISM	0.00357143	0.13398630442922801
IATROGENIC BOTULISM	0.00357143	0.13398630442922801
HINMAN SYNDROME	0.00357143	0.13398630442922801
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.13398630442922801
PUDENDAL NEURALGIA	0.00357143	0.13398630442922801
MYXEDEMA	0.00357143	0.13398630442922801
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13398630442922801
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13398630442922801
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13398630442922801
LIDDLE SYNDROME	0.00357143	0.13398630442922801
MALT LYMPHOMA	0.00357143	0.13398630442922801
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.13398630442922801
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13398630442922801
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13398630442922801
HIRSCHSPRUNG DISEASE	0.00357143	0.13398630442922801
OCHOA SYNDROME	0.00357143	0.13398630442922801
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13398630442922801
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.13117521929221512
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.13117521929221512
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.13117521929221512
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.13117521929221512
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.13117521929221512
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.13117521929221512
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.13117521929221512
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.13117521929221512
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.13117521929221512
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.13117521929221512
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.13117521929221512
CHROMOSOME 10Q26 DELETION SYNDROME	0.003447111	0.12932233414832173
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.003447111	0.12932233414832173
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003447111	0.12932233414832173
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003447111	0.12932233414832173
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003447111	0.12932233414832173
MEND SYNDROME; MEND	0.003447111	0.12932233414832173
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003447111	0.12932233414832173
ADENYLOSUCCINASE DEFICIENCY	0.003447111	0.12932233414832173
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003447111	0.12932233414832173
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003447111	0.12932233414832173
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.003447111	0.12932233414832173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003447111	0.12932233414832173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003447111	0.12932233414832173
BARAITSER-WINTER SYNDROME 1; BRWS1	0.003447111	0.12932233414832173
SIALURIA	0.003447111	0.12932233414832173
C SYNDROME	0.003447111	0.12932233414832173
JABERI-ELAHI SYNDROME; JABELS	0.003447111	0.12932233414832173
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.003447111	0.12932233414832173
VICI SYNDROME; VICIS	0.003447111	0.12932233414832173
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003447111	0.12932233414832173
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003447111	0.12932233414832173
MEND SYNDROME	0.003447111	0.12932233414832173
ZTTK SYNDROME; ZTTKS	0.003447111	0.12932233414832173
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003447111	0.12932233414832173
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.003447111	0.12932233414832173
TEMTAMY SYNDROME; TEMTYS	0.003447111	0.12932233414832173
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.003447111	0.12932233414832173
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.003447111	0.12932233414832173
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003447111	0.12932233414832173
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.003447111	0.12932233414832173
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003447111	0.12932233414832173
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.003447111	0.12932233414832173
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0034471109999999997	0.1293223341483217
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0034471109999999997	0.1293223341483217
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.003193432	0.1198052746731809
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.003193432	0.1198052746731809
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.003193432	0.1198052746731809
MARINESCO-SJOGREN SYNDROME; MSS	0.003193432	0.1198052746731809
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.003193432	0.1198052746731809
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003193432	0.1198052746731809
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.003193432	0.1198052746731809
PEROXISOME BIOGENESIS DISORDER 6B	0.003193432	0.1198052746731809
CEREBELLAR ATAXIA, CAYMAN TYPE	0.003193432	0.1198052746731809
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003193432	0.1198052746731809
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.003193432	0.1198052746731809
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003193432	0.1198052746731809
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003193432	0.1198052746731809
SPINOCEREBELLAR ATAXIA 5; SCA5	0.003193432	0.1198052746731809
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.003193432	0.1198052746731809
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0031892970000000002	0.11965014539196447
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0031892970000000002	0.11965014539196447
EPISODIC ATAXIA, TYPE 6	0.0031892970000000002	0.11965014539196447
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0031892970000000002	0.11965014539196447
HUNTINGTON DISEASE-LIKE 1	0.003189297	0.11965014539196445
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.003189297	0.11965014539196445
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.003189297	0.11965014539196445
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0030849399999999996	0.11573507250202374
OGDEN SYNDROME	0.0029056919999999997	0.10901037760492921
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0029056919999999997	0.10901037760492921
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0029056919999999997	0.10901037760492921
NOONAN SYNDROME 6; NS6	0.0029056919999999997	0.10901037760492921
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0029056919999999997	0.10901037760492921
LARSEN-LIKE SYNDROME	0.0029056919999999997	0.10901037760492921
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0029056919999999997	0.10901037760492921
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0029056919999999997	0.10901037760492921
CHROMOSOME 16Q22 DELETION SYNDROME	0.0029056919999999997	0.10901037760492921
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0029056919999999997	0.10901037760492921
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0029056919999999997	0.10901037760492921
LAMB-SHAFFER SYNDROME	0.0029056919999999997	0.10901037760492921
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0029056919999999997	0.10901037760492921
JOUBERT SYNDROME 14	0.0029056919999999997	0.10901037760492921
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0029056919999999997	0.10901037760492921
OROFACIODIGITAL SYNDROME VI	0.0029056919999999997	0.10901037760492921
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0029056919999999997	0.10901037760492921
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029056919999999997	0.10901037760492921
XIA-GIBBS SYNDROME	0.0029056919999999997	0.10901037760492921
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0029056919999999997	0.10901037760492921
DIAPHANOSPONDYLODYSOSTOSIS	0.0029056919999999997	0.10901037760492921
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0029056919999999997	0.10901037760492921
PEROXISOME BIOGENESIS DISORDER 10B	0.0029056919999999997	0.10901037760492921
RITSCHER-SCHINZEL SYNDROME 1	0.0029056919999999997	0.10901037760492921
MEVALONIC ACIDURIA; MEVA	0.0029056919999999997	0.10901037760492921
NOONAN SYNDROME 11; NS11	0.0029056919999999997	0.10901037760492921
GOLDBERG-SHPRINTZEN SYNDROME	0.0029056919999999997	0.10901037760492921
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0029056919999999997	0.10901037760492921
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0029056919999999997	0.10901037760492921
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029056919999999997	0.10901037760492921
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002901557	0.10885524832371278
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002901557	0.10885524832371278
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002901557	0.10885524832371278
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002901557	0.10885524832371278
LISSENCEPHALY, X-LINKED, 2	0.002901557	0.10885524832371278
MARDEN-WALKER SYNDROME	0.002901557	0.10885524832371278
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002901557	0.10885524832371278
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002901557	0.10885524832371278
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002901557	0.10885524832371278
GLUTAMINE DEFICIENCY, CONGENITAL	0.002901557	0.10885524832371278
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002901557	0.10885524832371278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002901557	0.10885524832371278
NON-DISTAL MONOSOMY 20Q	0.002901557	0.10885524832371278
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002901557	0.10885524832371278
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.002773313	0.1040440271531391
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002773313	0.1040440271531391
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002773313	0.1040440271531391
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002773313	0.1040440271531391
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.002773313	0.1040440271531391
WYBURN-MASON SYNDROME	0.002773313	0.1040440271531391
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.002773313	0.1040440271531391
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002773313	0.1040440271531391
HSD10 DISEASE	0.002773313	0.1040440271531391
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002773313	0.1040440271531391
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002773313	0.1040440271531391
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002773313	0.1040440271531391
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.002647878	0.09933818884857198
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.002647878	0.09933818884857198
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.002647878	0.09933818884857198
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002647878	0.09933818884857198
LESCH-NYHAN SYNDROME; LNS	0.002647878	0.09933818884857198
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.002647878	0.09933818884857198
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.002647878	0.09933818884857198
SPINOCEREBELLAR ATAXIA 13	0.002647878	0.09933818884857198
SYDENHAM CHOREA	0.002647878	0.09933818884857198
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.002647878	0.09933818884857198
SUSAC SYNDROME	0.002647878	0.09933818884857198
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.002647878	0.09933818884857198
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.002647878	0.09933818884857198
SPINOCEREBELLAR ATAXIA TYPE 1	0.002647878	0.09933818884857198
SPINOCEREBELLAR ATAXIA TYPE 2	0.002647878	0.09933818884857198
SPINOCEREBELLAR ATAXIA TYPE 14	0.002647878	0.09933818884857198
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0024855729999999996	0.09324913008488743
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0024855729999999996	0.09324913008488743
19P13.13 MICRODELETION SYNDROME	0.0024855729999999996	0.09324913008488743
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.0024855729999999996	0.09324913008488743
DISTAL MONOSOMY 1Q	0.0024855729999999996	0.09324913008488743
WALKER-WARBURG SYNDROME	0.0024855729999999996	0.09324913008488743
PFEIFFER SYNDROME TYPE 2	0.0024855729999999996	0.09324913008488743
GLYCEROL KINASE DEFICIENCY; GKD	0.0024855729999999996	0.09324913008488743
MYHRE SYNDROME	0.0024855729999999996	0.09324913008488743
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0024855729999999996	0.09324913008488743
GLASS SYNDROME	0.0024855729999999996	0.09324913008488743
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0024855729999999996	0.09324913008488743
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0024855729999999996	0.09324913008488743
3Q29 MICRODUPLICATION SYNDROME	0.0024855729999999996	0.09324913008488743
15Q14 MICRODELETION SYNDROME	0.0024855729999999996	0.09324913008488743
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0024855729999999996	0.09324913008488743
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.002360138	0.0885432917803203
PSEUDOTRISOMY 13 SYNDROME	0.002360138	0.0885432917803203
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002360138	0.0885432917803203
SIFRIM-HITZ-WEISS SYNDROME	0.002360138	0.0885432917803203
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002360138	0.0885432917803203
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.002360138	0.0885432917803203
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.002360138	0.0885432917803203
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.002360138	0.0885432917803203
CAMPOMELIC DYSPLASIA	0.002360138	0.0885432917803203
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002360138	0.0885432917803203
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.002360138	0.0885432917803203
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.002360138	0.0885432917803203
COFFIN-SIRIS SYNDROME 10; CSS10	0.002360138	0.0885432917803203
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.002360138	0.0885432917803203
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.002360138	0.0885432917803203
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.002360138	0.0885432917803203
JUVENILE POLYPOSIS OF INFANCY	0.002360138	0.0885432917803203
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.002360138	0.0885432917803203
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.002360138	0.0885432917803203
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.002360138	0.0885432917803203
JACOBSEN SYNDROME	0.002360138	0.0885432917803203
VERVERI-BRADY SYNDROME; VERBRAS	0.002360138	0.0885432917803203
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.002360138	0.0885432917803203
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002360138	0.0885432917803203
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.002360138	0.0885432917803203
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002360138	0.0885432917803203
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.002360138	0.0885432917803203
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002231894	0.08373207060974663
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.002231894	0.08373207060974663
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.002231894	0.08373207060974663
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.002231894	0.08373207060974663
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.002231894	0.08373207060974663
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.002231894	0.08373207060974663
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002231894	0.08373207060974663
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.002231894	0.08373207060974663
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.002231894	0.08373207060974663
SPINOCEREBELLAR ATAXIA TYPE 7	0.002231894	0.08373207060974663
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.002231894	0.08373207060974663
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.002231894	0.08373207060974663
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.002231894	0.08373207060974663
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.002231894	0.08373207060974663
PELLAGRA-LIKE SYNDROME	0.002231894	0.08373207060974663
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.002231894	0.08373207060974663
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.002231894	0.08373207060974663
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002231894	0.08373207060974663
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.002231894	0.08373207060974663
COCKAYNE SYNDROME A; CSA	0.002227759	0.08357694132853019
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.002227759	0.08357694132853019
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.002227759	0.08357694132853019
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002227759	0.08357694132853019
CEREBELLOPARENCHYMAL DISORDER II	0.002227759	0.08357694132853019
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.002227759	0.08357694132853019
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.002227759	0.08357694132853019
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002227759	0.08357694132853019
PARTINGTON SYNDROME	0.002227759	0.08357694132853019
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002227759	0.08357694132853019
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002227759	0.08357694132853019
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002227759	0.08357694132853019
KALLMANN SYNDROME	0.002227759	0.08357694132853019
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.002227759	0.08357694132853019
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002227759	0.08357694132853019
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002227759	0.08357694132853019
ATAXIA-TELANGIECTASIA	0.002227759	0.08357694132853019
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.002227759	0.08357694132853019
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.002227759	0.08357694132853019
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002227759	0.08357694132853019
FAMILIAL THROMBOCYTOSIS	0.002227759	0.08357694132853019
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002227759	0.08357694132853019
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.002227759	0.08357694132853019
SUPRABULBAR PARESIS, CONGENITAL	0.002227759	0.08357694132853019
SNEDDON SYNDROME	0.002227759	0.08357694132853019
SJÖGREN-LARSSON SYNDROME	0.002227759	0.08357694132853019
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002227759	0.08357694132853019
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.002227759	0.08357694132853019
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002227759	0.08357694132853019
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.002227759	0.08357694132853019
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.002227759	0.08357694132853019
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002227759	0.08357694132853019
MYASTHENIA GRAVIS	0.002227759	0.08357694132853019
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.002227759	0.08357694132853019
OCULOCEREBROCUTANEOUS SYNDROME	0.002227759	0.08357694132853019
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002227759	0.08357694132853019
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002227759	0.08357694132853019
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002227759	0.08357694132853019
INFANTILE LIVER FAILURE SYNDROME 1	0.0020485110000000003	0.07685224643143568
CHROMOSOME 5Q12 DELETION SYNDROME	0.0020485110000000003	0.07685224643143568
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0020485110000000003	0.07685224643143568
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0020485110000000003	0.07685224643143568
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
XQ25 MICRODUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0020485110000000003	0.07685224643143568
JOUBERT SYNDROME 30; JBTS30	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0020485110000000003	0.07685224643143568
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0020485110000000003	0.07685224643143568
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0020485110000000003	0.07685224643143568
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0020485110000000003	0.07685224643143568
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0020485110000000003	0.07685224643143568
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0020485110000000003	0.07685224643143568
ELEJALDE DISEASE	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0020485110000000003	0.07685224643143568
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0020485110000000003	0.07685224643143568
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0020485110000000003	0.07685224643143568
KETOADIPICACIDURIA	0.0020485110000000003	0.07685224643143568
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0020485110000000003	0.07685224643143568
ADAMS-OLIVER SYNDROME 1; AOS1	0.0020485110000000003	0.07685224643143568
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0020485110000000003	0.07685224643143568
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0020485110000000003	0.07685224643143568
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0020485110000000003	0.07685224643143568
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0020485110000000003	0.07685224643143568
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0020485110000000003	0.07685224643143568
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0020485110000000003	0.07685224643143568
PYRUVATE CARBOXYLASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0020485110000000003	0.07685224643143568
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0020485110000000003	0.07685224643143568
GRISCELLI SYNDROME, TYPE 1	0.0020485110000000003	0.07685224643143568
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0020485110000000003	0.07685224643143568
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0020485110000000003	0.07685224643143568
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0020485110000000003	0.07685224643143568
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0020485110000000003	0.07685224643143568
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0020485110000000003	0.07685224643143568
PEHO SYNDROME; PEHO	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0020485110000000003	0.07685224643143568
SCHINDLER DISEASE, TYPE I	0.0020485110000000003	0.07685224643143568
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0020485110000000003	0.07685224643143568
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0020485110000000003	0.07685224643143568
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0020485110000000003	0.07685224643143568
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0020485110000000003	0.07685224643143568
HELSMOORTEL-VAN DER AA SYNDROME	0.0020485110000000003	0.07685224643143568
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0020485110000000003	0.07685224643143568
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0020485110000000003	0.07685224643143568
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0020485110000000003	0.07685224643143568
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0020485110000000003	0.07685224643143568
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0020485110000000003	0.07685224643143568
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0020485110000000003	0.07685224643143568
GRISCELLI SYNDROME TYPE 1	0.0020485110000000003	0.07685224643143568
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0020485110000000003	0.07685224643143568
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0020485110000000003	0.07685224643143568
FOLATE MALABSORPTION, HEREDITARY	0.0020485110000000003	0.07685224643143568
SHUKLA-VERNON SYNDROME; SHUVER	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0020485110000000003	0.07685224643143568
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0020485110000000003	0.07685224643143568
XQ25 DUPLICATION SYNDROME	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0020485110000000003	0.07685224643143568
STT3A-CDG	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0020485110000000003	0.07685224643143568
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0020485110000000003	0.07685224643143568
HOLOPROSENCEPHALY 1; HPE1	0.0020485110000000003	0.07685224643143568
TIMOTHY SYNDROME; TS	0.0020485110000000003	0.07685224643143568
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0020485110000000003	0.07685224643143568
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0020485110000000003	0.07685224643143568
PRADER-WILLI SYNDROME; PWS	0.0020485110000000003	0.07685224643143568
PETTIGREW SYNDROME	0.0020485110000000003	0.07685224643143568
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0020485110000000003	0.07685224643143568
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0020485110000000003	0.07685224643143568
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0020485110000000003	0.07685224643143568
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0020485110000000003	0.07685224643143568
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0020485110000000003	0.07685224643143568
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0020485110000000003	0.07685224643143568
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0020485110000000003	0.07685224643143568
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0020485110000000003	0.07685224643143568
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, X-LINKED 90	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0020485110000000003	0.07685224643143568
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0020485110000000003	0.07685224643143568
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0020485110000000003	0.07685224643143568
OROFACIODIGITAL SYNDROME TYPE 6	0.0020485110000000003	0.07685224643143568
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0020485110000000003	0.07685224643143568
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0020485110000000003	0.07685224643143568
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0020485110000000003	0.07685224643143568
STT3B-CDG	0.0020485110000000003	0.07685224643143568
MARDEN-WALKER SYNDROME	0.0019441539999999998	0.07293717354149495
ALAZAMI SYNDROME; ALAZS	0.0019441539999999998	0.07293717354149495
CREE MENTAL RETARDATION SYNDROME	0.0019441539999999998	0.07293717354149495
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0019441539999999998	0.07293717354149495
CHAR SYNDROME	0.0019441539999999998	0.07293717354149495
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0019441539999999998	0.07293717354149495
ELSAHY-WATERS SYNDROME; ESWS	0.0019441539999999998	0.07293717354149495
FRONTOOCULAR SYNDROME	0.0019441539999999998	0.07293717354149495
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0019441539999999998	0.07293717354149495
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0019441539999999998	0.07293717354149495
HARTSFIELD SYNDROME; HRTFDS	0.0019441539999999998	0.07293717354149495
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0019441539999999998	0.07293717354149495
8Q22.1 MICRODELETION SYNDROME	0.0019441539999999998	0.07293717354149495
TEMTAMY SYNDROME	0.0019441539999999998	0.07293717354149495
DIAMOND-BLACKFAN ANEMIA 5	0.0019441539999999998	0.07293717354149495
6Q16 MICRODELETION SYNDROME	0.0019441539999999998	0.07293717354149495
DISTAL TRISOMY 6P	0.0019441539999999998	0.07293717354149495
NOONAN SYNDROME 5; NS5	0.0019441539999999998	0.07293717354149495
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0019441539999999998	0.07293717354149495
OPITZ G/BBB SYNDROME	0.0019441539999999998	0.07293717354149495
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0019441539999999998	0.07293717354149495
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0019441539999999998	0.07293717354149495
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0019441539999999998	0.07293717354149495
CEREBELLOFACIODENTAL SYNDROME	0.0019441539999999998	0.07293717354149495
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0019441539999999998	0.07293717354149495
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0019441539999999998	0.07293717354149495
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.07293717354149495
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0019441539999999998	0.07293717354149495
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.0019441539999999998	0.07293717354149495
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.0019441539999999998	0.07293717354149495
EAR-PATELLA-SHORT STATURE SYNDROME	0.0019441539999999998	0.07293717354149495
OTOPALATODIGITAL SYNDROME TYPE 2	0.0019441539999999998	0.07293717354149495
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0019441539999999998	0.07293717354149495
TRISOMY 12P	0.0019441539999999998	0.07293717354149495
OGDEN SYNDROME; OGDNS	0.0019441539999999998	0.07293717354149495
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0019441539999999998	0.07293717354149495
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0019441539999999998	0.07293717354149495
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0019441539999999998	0.07293717354149495
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0019441539999999998	0.07293717354149495
TRISOMY 17P	0.0019441539999999998	0.07293717354149495
FORSYTHE-WAKELING SYNDROME; FWS	0.0019441539999999998	0.07293717354149495
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0019441539999999998	0.07293717354149495
17P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.07293717354149495
ZECHI-CEIDE SYNDROME	0.0019441539999999998	0.07293717354149495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0019441539999999998	0.07293717354149495
CHROMOSOME 15Q14 DELETION SYNDROME	0.0019441539999999998	0.07293717354149495
NOONAN SYNDROME 3; NS3	0.0019441539999999998	0.07293717354149495
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0019441539999999998	0.07293717354149495
PHENOBARBITAL EMBRYOPATHY	0.0019441539999999998	0.07293717354149495
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0019441539999999998	0.07293717354149495
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0019441539999999998	0.07293717354149495
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0019441539999999998	0.07293717354149495
DISTAL MONOSOMY 6P	0.0019441539999999998	0.07293717354149495
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0019400189999999999	0.07278204426027851
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0019400189999999999	0.07278204426027851
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0019400189999999999	0.07278204426027851
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0019400189999999999	0.07278204426027851
COG5-CDG	0.0019400189999999999	0.07278204426027851
RING CHROMOSOME 10 SYNDROME	0.0019400189999999999	0.07278204426027851
4Q21 MICRODELETION SYNDROME	0.0019400189999999999	0.07278204426027851
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0019400189999999999	0.07278204426027851
THANATOPHORIC DYSPLASIA	0.0019400189999999999	0.07278204426027851
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0019400189999999999	0.07278204426027851
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0019400189999999999	0.07278204426027851
AICA-RIBOSIDURIA	0.0019400189999999999	0.07278204426027851
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0019400189999999999	0.07278204426027851
PFEIFFER SYNDROME TYPE 3	0.0019400189999999999	0.07278204426027851
AYME-GRIPP SYNDROME; AYGRP	0.0019400189999999999	0.07278204426027851
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0019400189999999999	0.07278204426027851
CONO-SPONDYLAR DYSPLASIA	0.0019400189999999999	0.07278204426027851
OROFACIODIGITAL SYNDROME I; OFD1	0.0019400189999999999	0.07278204426027851
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0019400189999999999	0.07278204426027851
HENNEKAM SYNDROME	0.0019400189999999999	0.07278204426027851
20P13 MICRODELETION SYNDROME	0.0019400189999999999	0.07278204426027851
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.0019400189999999999	0.07278204426027851
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0019400189999999999	0.07278204426027851
ACROCARDIOFACIAL SYNDROME	0.0019400189999999999	0.07278204426027851
47,XYY SYNDROME	0.0019400189999999999	0.07278204426027851
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0019400189999999999	0.07278204426027851
EDINBURGH MALFORMATION SYNDROME	0.0019400189999999999	0.07278204426027851
SPINOCEREBELLAR ATAXIA TYPE 6	0.00168634	0.06326498478513772
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06326498478513772
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00168634	0.06326498478513772
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00168634	0.06326498478513772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00168634	0.06326498478513772
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00168634	0.06326498478513772
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00168634	0.06326498478513772
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00168634	0.06326498478513772
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00168634	0.06326498478513772
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00168634	0.06326498478513772
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00168634	0.06326498478513772
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 3	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 42	0.00168634	0.06326498478513772
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00168634	0.06326498478513772
TREMOR, HEREDITARY ESSENTIAL, 1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00168634	0.06326498478513772
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00168634	0.06326498478513772
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00168634	0.06326498478513772
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00168634	0.06326498478513772
EPISODIC ATAXIA, TYPE 5	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 42	0.00168634	0.06326498478513772
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00168634	0.06326498478513772
WILSON DISEASE	0.00168634	0.06326498478513772
ERDHEIM-CHESTER DISEASE	0.00168634	0.06326498478513772
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00168634	0.06326498478513772
PURE MITOCHONDRIAL MYOPATHY	0.00168634	0.06326498478513772
EPISODIC ATAXIA TYPE 5	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 30	0.00168634	0.06326498478513772
UROCANIC ACIDURIA	0.00168634	0.06326498478513772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00168634	0.06326498478513772
EPISODIC ATAXIA TYPE 7	0.00168634	0.06326498478513772
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00168634	0.06326498478513772
DISTAL MYOTILINOPATHY	0.00168634	0.06326498478513772
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00168634	0.06326498478513772
SYRINGOMYELIA, ISOLATED	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00168634	0.06326498478513772
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00168634	0.06326498478513772
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00168634	0.06326498478513772
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 12	0.00168634	0.06326498478513772
MYOPATHY AND DIABETES MELLITUS	0.00168634	0.06326498478513772
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00168634	0.06326498478513772
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00168634	0.06326498478513772
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00168634	0.06326498478513772
MACHADO-JOSEPH DISEASE; MJD	0.00168634	0.06326498478513772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00168634	0.06326498478513772
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
ALLAN-HERNDON-DUDLEY SYNDROME	0.00168634	0.06326498478513772
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 4	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 14	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00168634	0.06326498478513772
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00168634	0.06326498478513772
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00168634	0.06326498478513772
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00168634	0.06326498478513772
HUNTINGTON DISEASE-LIKE 2	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00168634	0.06326498478513772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00168634	0.06326498478513772
OPTIC ATROPHY 2	0.00168634	0.06326498478513772
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00168634	0.06326498478513772
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00168634	0.06326498478513772
INTESTINAL BOTULISM	0.00168634	0.06326498478513772
CHIARI MALFORMATION TYPE I	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 31	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00168634	0.06326498478513772
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00168634	0.06326498478513772
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00168634	0.06326498478513772
LEBER OPTIC ATROPHY AND DYSTONIA	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA TYPE 2	0.00168634	0.06326498478513772
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00168634	0.06326498478513772
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00168634	0.06326498478513772
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00168634	0.06326498478513772
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00168634	0.06326498478513772
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00168634	0.06326498478513772
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00168634	0.06326498478513772
EPISODIC ATAXIA, TYPE 7; EA7	0.00168634	0.06326498478513772
EPISODIC ATAXIA TYPE 1	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00168634	0.06326498478513772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00168634	0.06326498478513772
PRIMARY DYSTONIA, DYT2 TYPE	0.00168634	0.06326498478513772
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00168634	0.06326498478513772
ACHONDROPLASIA	0.00168634	0.06326498478513772
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00168634	0.06326498478513772
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 11	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 38	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 36	0.00168634	0.06326498478513772
MACHADO-JOSEPH DISEASE TYPE 1	0.00168634	0.06326498478513772
MACHADO-JOSEPH DISEASE TYPE 2	0.00168634	0.06326498478513772
MACHADO-JOSEPH DISEASE TYPE 3	0.00168634	0.06326498478513772
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00168634	0.06326498478513772
POSTPOLIOMYELITIS SYNDROME	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00168634	0.06326498478513772
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00168634	0.06326498478513772
PERRY SYNDROME	0.00168634	0.06326498478513772
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 18	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00168634	0.06326498478513772
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00168634	0.06326498478513772
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00168634	0.06326498478513772
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA TYPE 7	0.00168634	0.06326498478513772
POSTORGASMIC ILLNESS SYNDROME	0.00168634	0.06326498478513772
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00168634	0.06326498478513772
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00168634	0.06326498478513772
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00168634	0.06326498478513772
UNVERRICHT-LUNDBORG DISEASE	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00168634	0.06326498478513772
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00168634	0.06326498478513772
SANDHOFF DISEASE	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00168634	0.06326498478513772
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00168634	0.06326498478513772
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 43	0.00168634	0.06326498478513772
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 31	0.00168634	0.06326498478513772
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00168634	0.06326498478513772
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00168634	0.06326498478513772
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00168634	0.06326498478513772
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00168634	0.06326498478513772
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00168634	0.06326498478513772
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00168634	0.06326498478513772
HUNTINGTON DISEASE-LIKE 1	0.00168634	0.06326498478513772
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00168634	0.06326498478513772
FAMILIAL PAROXYSMAL ATAXIA	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 28	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 23	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00168634	0.06326498478513772
EPISODIC ATAXIA, TYPE 8	0.00168634	0.06326498478513772
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00168634	0.06326498478513772
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00168634	0.06326498478513772
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.00168634	0.06326498478513772
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00168634	0.06326498478513772
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00168634	0.06326498478513772
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00168634	0.06326498478513772
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00168634	0.06326498478513772
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00168634	0.06326498478513772
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00168634	0.06326498478513772
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00168634	0.06326498478513772
MYASTHENIA GRAVIS; MG	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
EPISODIC ATAXIA, TYPE 2	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA TYPE 26	0.00168634	0.06326498478513772
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00168634	0.06326498478513772
ATAXIA WITH VITAMIN E DEFICIENCY	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00168634	0.06326498478513772
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00168634	0.06326498478513772
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00168634	0.06326498478513772
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00168634	0.06326498478513772
ACERULOPLASMINEMIA	0.00168634	0.06326498478513772
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 26	0.00168634	0.06326498478513772
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00168634	0.06326498478513772
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00168634	0.06326498478513772
WOODHOUSE-SAKATI SYNDROME	0.00168634	0.06326498478513772
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00168634	0.06326498478513772
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00168634	0.06326498478513772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001507092	0.05654028988804319
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001507092	0.05654028988804319
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001507092	0.05654028988804319
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.05654028988804319
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.05654028988804319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.05654028988804319
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.05654028988804319
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.05654028988804319
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.05654028988804319
JOUBERT SYNDROME 26	0.001507092	0.05654028988804319
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.05654028988804319
MICROPHTHALMIA, SYNDROMIC 3	0.001507092	0.05654028988804319
NAVAJO NEUROHEPATOPATHY	0.001507092	0.05654028988804319
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.05654028988804319
HYPOTONIA-CYSTINURIA SYNDROME	0.001507092	0.05654028988804319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001507092	0.05654028988804319
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.05654028988804319
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.05654028988804319
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.05654028988804319
GALACTOSE EPIMERASE DEFICIENCY	0.001507092	0.05654028988804319
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001507092	0.05654028988804319
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.001507092	0.05654028988804319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.05654028988804319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.001507092	0.05654028988804319
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001507092	0.05654028988804319
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.05654028988804319
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001507092	0.05654028988804319
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.05654028988804319
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.05654028988804319
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001507092	0.05654028988804319
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001507092	0.05654028988804319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.05654028988804319
ARIMA SYNDROME	0.001507092	0.05654028988804319
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001507092	0.05654028988804319
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.05654028988804319
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001507092	0.05654028988804319
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.05654028988804319
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001507092	0.05654028988804319
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001507092	0.05654028988804319
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001507092	0.05654028988804319
RIGID SPINE SYNDROME	0.001507092	0.05654028988804319
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.05654028988804319
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.05654028988804319
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.05654028988804319
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001507092	0.05654028988804319
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001507092	0.05654028988804319
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.05654028988804319
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.05654028988804319
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001507092	0.05654028988804319
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.05654028988804319
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.05654028988804319
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.05654028988804319
AURICULOCONDYLAR SYNDROME	0.001507092	0.05654028988804319
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001507092	0.05654028988804319
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001507092	0.05654028988804319
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.05654028988804319
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.05654028988804319
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001507092	0.05654028988804319
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.05654028988804319
GENITOPATELLAR SYNDROME; GTPTS	0.001507092	0.05654028988804319
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001507092	0.05654028988804319
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.05654028988804319
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.05654028988804319
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001507092	0.05654028988804319
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.001502957	0.05638516060682675
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.001502957	0.05638516060682675
NEURAMINIDASE DEFICIENCY	0.001502957	0.05638516060682675
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.001502957	0.05638516060682675
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.001502957	0.05638516060682675
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001502957	0.05638516060682675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.001502957	0.05638516060682675
CYCLIC VOMITING SYNDROME	0.001502957	0.05638516060682675
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001502957	0.05638516060682675
XYLOSIDASE DEFICIENCY	0.001502957	0.05638516060682675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.001502957	0.05638516060682675
MENKES DISEASE	0.001502957	0.05638516060682675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.05638516060682675
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.05638516060682675
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.001502957	0.05638516060682675
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.05638516060682675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001502957	0.05638516060682675
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001502957	0.05638516060682675
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001502957	0.05638516060682675
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.05638516060682675
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.05638516060682675
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.001502957	0.05638516060682675
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001502957	0.05638516060682675
PSEUDO-TORCH SYNDROME 2	0.001502957	0.05638516060682675
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.05638516060682675
MAPLE SYRUP URINE DISEASE; MSUD	0.001502957	0.05638516060682675
GLYCINE ENCEPHALOPATHY; GCE	0.001502957	0.05638516060682675
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001502957	0.05638516060682675
TAY-SACHS DISEASE; TSD	0.001502957	0.05638516060682675
ASPARTYLGLUCOSAMINURIA; AGU	0.001502957	0.05638516060682675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001502957	0.05638516060682675
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001502957	0.05638516060682675
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.001502957	0.05638516060682675
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001502957	0.05638516060682675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.001502957	0.05638516060682675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.001502957	0.05638516060682675
LISSENCEPHALY 3; LIS3	0.001502957	0.05638516060682675
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.001502957	0.05638516060682675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.001502957	0.05638516060682675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001502957	0.05638516060682675
ETHYLMALONIC ENCEPHALOPATHY	0.001502957	0.05638516060682675
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.05638516060682675
LISSENCEPHALY 5; LIS5	0.001502957	0.05638516060682675
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.05638516060682675
OHDO SYNDROME	0.001502957	0.05638516060682675
LATHOSTEROLOSIS	0.001502957	0.05638516060682675
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.05638516060682675
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001502957	0.05638516060682675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001502957	0.05638516060682675
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.05638516060682675
MENTAL RETARDATION, X-LINKED 102	0.001502957	0.05638516060682675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001502957	0.05638516060682675
GLUTARIC ACIDEMIA I; GA1	0.001502957	0.05638516060682675
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001502957	0.05638516060682675
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.05638516060682675
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001502957	0.05638516060682675
VISCERAL STEATOSIS, CONGENITAL	0.001502957	0.05638516060682675
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001502957	0.05638516060682675
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001502957	0.05638516060682675
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.001502957	0.05638516060682675
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.05638516060682675
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.0013985999999999998	0.052470087716886035
PELVISCAPULAR DYSPLASIA	0.0013985999999999998	0.052470087716886035
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0013985999999999998	0.052470087716886035
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0013985999999999998	0.052470087716886035
TRISOMY 18-LIKE SYNDROME	0.0013985999999999998	0.052470087716886035
OROFACIODIGITAL SYNDROME XVII	0.0013985999999999998	0.052470087716886035
CEREBROOCULONASAL SYNDROME	0.0013985999999999998	0.052470087716886035
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0013985999999999998	0.052470087716886035
CAMPOMELIC DYSPLASIA	0.0013985999999999998	0.052470087716886035
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0013985999999999998	0.052470087716886035
TETRAAMELIA SYNDROME 2; TETAMS2	0.0013985999999999998	0.052470087716886035
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.0013985999999999998	0.052470087716886035
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0013985999999999998	0.052470087716886035
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0013985999999999998	0.052470087716886035
ACRORENAL-MANDIBULAR SYNDROME	0.0013985999999999998	0.052470087716886035
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0013985999999999998	0.052470087716886035
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0013985999999999998	0.052470087716886035
TRANSALDOLASE DEFICIENCY	0.0013985999999999998	0.052470087716886035
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0013985999999999998	0.052470087716886035
PFEIFFER SYNDROME TYPE 1	0.0013985999999999998	0.052470087716886035
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0013985999999999998	0.052470087716886035
JUVENILE POLYPOSIS SYNDROME	0.0013985999999999998	0.052470087716886035
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0013985999999999998	0.052470087716886035
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0013985999999999998	0.052470087716886035
SPONDYLOOCULAR SYNDROME; SOS	0.0013985999999999998	0.052470087716886035
PYKNOACHONDROGENESIS	0.0013985999999999998	0.052470087716886035
HAMAMY SYNDROME; HMMS	0.0013985999999999998	0.052470087716886035
ULBRIGHT-HODES SYNDROME	0.0013985999999999998	0.052470087716886035
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0013985999999999998	0.052470087716886035
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0013985999999999998	0.052470087716886035
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0013985999999999998	0.052470087716886035
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0013985999999999998	0.052470087716886035
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0013985999999999998	0.052470087716886035
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.052470087716886035
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0013985999999999998	0.052470087716886035
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0013985999999999998	0.052470087716886035
OROFACIODIGITAL SYNDROME III	0.0013985999999999998	0.052470087716886035
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0013985999999999998	0.052470087716886035
LETHAL KNIEST-LIKE DYSPLASIA	0.0013985999999999998	0.052470087716886035
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0013985999999999998	0.052470087716886035
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0013985999999999998	0.052470087716886035
STROMME SYNDROME; STROMS	0.0013985999999999998	0.052470087716886035
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0013985999999999998	0.052470087716886035
NOONAN SYNDROME 8; NS8	0.0013985999999999998	0.052470087716886035
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0013985999999999998	0.052470087716886035
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0013985999999999998	0.052470087716886035
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0013985999999999998	0.052470087716886035
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0013985999999999998	0.052470087716886035
BARTSOCAS-PAPAS SYNDROME; BPS	0.0013985999999999998	0.052470087716886035
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0013985999999999998	0.052470087716886035
MATTHEW-WOOD SYNDROME	0.0013985999999999998	0.052470087716886035
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0013985999999999998	0.052470087716886035
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0013985999999999998	0.052470087716886035
ROBERTS SYNDROME; RBS	0.0013985999999999998	0.052470087716886035
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0013985999999999998	0.052470087716886035
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0013985999999999998	0.052470087716886035
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0013985999999999998	0.052470087716886035
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.0013985999999999998	0.052470087716886035
MEIER-GORLIN SYNDROME 8; MGORS8	0.0013985999999999998	0.052470087716886035
RESTRICTIVE DERMOPATHY	0.0013985999999999998	0.052470087716886035
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.0013985999999999998	0.052470087716886035
16P12.1P12.3 TRIPLICATION SYNDROME	0.0013985999999999998	0.052470087716886035
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0013985999999999998	0.052470087716886035
OTOFACIOCERVICAL SYNDROME 2	0.0013985999999999998	0.052470087716886035
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.0013985999999999998	0.052470087716886035
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.052470087716886035
IMAGE SYNDROME	0.0013985999999999998	0.052470087716886035
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0013985999999999998	0.052470087716886035
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0013985999999999998	0.052470087716886035
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0013985999999999998	0.052470087716886035
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.0013985999999999998	0.052470087716886035
MECKEL SYNDROME 12; MKS12	0.0013985999999999998	0.052470087716886035
FRANK-TER HAAR SYNDROME; FTHS	0.0013985999999999998	0.052470087716886035
NEU-LAXOVA SYNDROME 2; NLS2	0.0013985999999999998	0.052470087716886035
FRONTONASAL DYSPLASIA 1; FND1	0.0013985999999999998	0.052470087716886035
INIENCEPHALY	0.0013985999999999998	0.052470087716886035
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0013985999999999998	0.052470087716886035
MECKEL SYNDROME, TYPE 1; MKS1	0.0013985999999999998	0.052470087716886035
PRIMARY PULMONARY HYPOPLASIA	0.0013985999999999998	0.052470087716886035
OROFACIODIGITAL SYNDROME IV; OFD4	0.0013985999999999998	0.052470087716886035
SPONDYLO-OCULAR SYNDROME	0.0013985999999999998	0.052470087716886035
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0013985999999999998	0.052470087716886035
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0013985999999999998	0.052470087716886035
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0013985999999999998	0.052470087716886035
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0013985999999999998	0.052470087716886035
NEMALINE MYOPATHY 2; NEM2	0.0013985999999999998	0.052470087716886035
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.052470087716886035
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0013985999999999998	0.052470087716886035
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0013985999999999998	0.052470087716886035
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0013985999999999998	0.052470087716886035
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0013985999999999998	0.052470087716886035
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0013985999999999998	0.052470087716886035
TRICHOHEPATOENTERIC SYNDROME 1	0.0013985999999999998	0.052470087716886035
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0013985999999999998	0.052470087716886035
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0013985999999999998	0.052470087716886035
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0013985999999999998	0.052470087716886035
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0013985999999999998	0.052470087716886035
SECKEL SYNDROME 4	0.0013985999999999998	0.052470087716886035
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0013985999999999998	0.052470087716886035
3Q27.3 MICRODELETION SYNDROME	0.0013985999999999998	0.052470087716886035
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0013985999999999998	0.052470087716886035
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0013985999999999998	0.052470087716886035
HYPOGLOSSIA WITH SITUS INVERSUS	0.0013985999999999998	0.052470087716886035
RENAL AGENESIS, BILATERAL	0.0013985999999999998	0.052470087716886035
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.0013985999999999998	0.052470087716886035
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0013985999999999998	0.052470087716886035
BARBER-SAY SYNDROME; BBRSAY	0.0013985999999999998	0.052470087716886035
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0013985999999999998	0.052470087716886035
DIAMOND-BLACKFAN ANEMIA 10	0.0013985999999999998	0.052470087716886035
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0013985999999999998	0.052470087716886035
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0013985999999999998	0.052470087716886035
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0013985999999999998	0.052470087716886035
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0013985999999999998	0.052470087716886035
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0013985999999999998	0.052470087716886035
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0013985999999999998	0.052470087716886035
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0013985999999999998	0.052470087716886035
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0013985999999999998	0.052470087716886035
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0013985999999999998	0.052470087716886035
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0013985999999999998	0.052470087716886035
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0013985999999999998	0.052470087716886035
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0013985999999999998	0.052470087716886035
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0013985999999999998	0.052470087716886035
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.052470087716886035
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0013985999999999998	0.052470087716886035
FEMORAL-FACIAL SYNDROME	0.0013985999999999998	0.052470087716886035
HYDROLETHALUS SYNDROME 1	0.0013985999999999998	0.052470087716886035
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0013985999999999998	0.052470087716886035
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0013985999999999998	0.052470087716886035
FEINGOLD SYNDROME 1; FGLDS1	0.0013985999999999998	0.052470087716886035
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0013985999999999998	0.052470087716886035
KYPHOMELIC DYSPLASIA	0.0013985999999999998	0.052470087716886035
ATELOSTEOGENESIS TYPE I	0.0013985999999999998	0.052470087716886035
PHAVER SYNDROME	0.0013985999999999998	0.052470087716886035
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0013985999999999998	0.052470087716886035
MACDERMOT-WINTER SYNDROME	0.001086973	0.0407790423680014
DISTAL TRISOMY 17Q	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.0407790423680014
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.0407790423680014
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.0407790423680014
ALG1-CDG	0.001086973	0.0407790423680014
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.0407790423680014
ALG3-CDG	0.001086973	0.0407790423680014
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.0407790423680014
SCHIZENCEPHALY	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.0407790423680014
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.0407790423680014
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.0407790423680014
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
HARTNUP DISORDER	0.001086973	0.0407790423680014
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.0407790423680014
ISOVALERIC ACIDEMIA	0.001086973	0.0407790423680014
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.0407790423680014
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.0407790423680014
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.0407790423680014
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.0407790423680014
INFANTILE REFSUM DISEASE	0.001086973	0.0407790423680014
TRISOMY X	0.001086973	0.0407790423680014
PMM2-CDG	0.001086973	0.0407790423680014
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.0407790423680014
CEDNIK SYNDROME	0.001086973	0.0407790423680014
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.0407790423680014
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.0407790423680014
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.0407790423680014
LATHOSTEROLOSIS	0.001086973	0.0407790423680014
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.0407790423680014
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.0407790423680014
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.0407790423680014
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.0407790423680014
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.0407790423680014
DPAGT1-CDG	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.0407790423680014
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.0407790423680014
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
PHACE SYNDROME	0.001086973	0.0407790423680014
TAY-SACHS DISEASE	0.001086973	0.0407790423680014
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.0407790423680014
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.0407790423680014
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.0407790423680014
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.0407790423680014
OCULOECTODERMAL SYNDROME; OES	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.0407790423680014
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
ARGININOSUCCINIC ACIDURIA	0.001086973	0.0407790423680014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.0407790423680014
GRISCELLI SYNDROME	0.001086973	0.0407790423680014
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.0407790423680014
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.0407790423680014
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.0407790423680014
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.0407790423680014
LEBER CONGENITAL AMAUROSIS	0.001086973	0.0407790423680014
NARP SYNDROME	0.001086973	0.0407790423680014
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.0407790423680014
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.0407790423680014
ALSTRÖM SYNDROME	0.001086973	0.0407790423680014
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.0407790423680014
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.0407790423680014
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.0407790423680014
POTOCKI-SHAFFER SYNDROME	0.001086973	0.0407790423680014
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.0407790423680014
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
CRANIOPHARYNGIOMA	0.001086973	0.0407790423680014
KEUTEL SYNDROME	0.001086973	0.0407790423680014
CITRULLINEMIA, CLASSIC	0.001086973	0.0407790423680014
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.0407790423680014
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.0407790423680014
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.0407790423680014
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.0407790423680014
MAPLE SYRUP URINE DISEASE	0.001086973	0.0407790423680014
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.0407790423680014
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.0407790423680014
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.0407790423680014
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.0407790423680014
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.0407790423680014
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.0407790423680014
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.0407790423680014
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.0407790423680014
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.0407790423680014
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.0407790423680014
17Q12 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
20P12.3 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.0407790423680014
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.0407790423680014
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.0407790423680014
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.0407790423680014
XP21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
MATERNAL PHENYLKETONURIA	0.001086973	0.0407790423680014
HYDRANENCEPHALY	0.001086973	0.0407790423680014
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.0407790423680014
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.0407790423680014
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.0407790423680014
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.0407790423680014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.0407790423680014
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.0407790423680014
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.0407790423680014
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.0407790423680014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.0407790423680014
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.0407790423680014
MICRO SYNDROME	0.001086973	0.0407790423680014
8P11.2 DELETION SYNDROME	0.001086973	0.0407790423680014
1Q21.1 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.0407790423680014
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.0407790423680014
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.0407790423680014
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.0407790423680014
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.0407790423680014
PALLISTER-HALL SYNDROME	0.001086973	0.0407790423680014
2P21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
HOLOPROSENCEPHALY 7	0.001086973	0.0407790423680014
RFT1-CDG	0.001086973	0.0407790423680014
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.0407790423680014
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.0407790423680014
XQ21 MICRODELETION SYNDROME	0.001086973	0.0407790423680014
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.0407790423680014
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.0407790423680014
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.0407790423680014
SRD5A3-CDG	0.001086973	0.0407790423680014
MEVALONIC ACIDURIA	0.001086973	0.0407790423680014
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.0407790423680014
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.0407790423680014
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.0407790423680014
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407790423680014
RUVALCABA SYNDROME	0.001086973	0.0407790423680014
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407790423680014
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.0407790423680014
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.0407790423680014
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.0407790423680014
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.0407790423680014
PHACE ASSOCIATION	0.001086973	0.0407790423680014
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.0407790423680014
LISSENCEPHALY 1; LIS1	0.001086973	0.0407790423680014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.0407790423680014
COWDEN SYNDROME	0.001086973	0.0407790423680014
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.0407790423680014
L1 SYNDROME	0.001086973	0.0407790423680014
EAST SYNDROME	0.001086973	0.0407790423680014
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.0407790423680014
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.0407790423680014
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.0407790423680014
ALG11-CDG	0.001086973	0.0407790423680014
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001086973	0.0407790423680014
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.0407790423680014
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.0407790423680014
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.0407790423680014
VICI SYNDROME	0.001086973	0.0407790423680014
SOTOS SYNDROME	0.001086973	0.0407790423680014
LISSENCEPHALY 4	0.001086973	0.0407790423680014
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.0407790423680014
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.0407790423680014
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.0407790423680014
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.0407790423680014
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.0407790423680014
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.0407790423680014
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.0407790423680014
HARTNUP DISEASE	0.001086973	0.0407790423680014
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.0407790423680014
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.0407790423680014
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.0407790423680014
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.0407790423680014
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.0407790423680014
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.0407790423680014
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.0407790423680014
OPTIC PATHWAY GLIOMA	0.001086973	0.0407790423680014
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.0407790423680014
WOLF-HIRSCHHORN SYNDROME	0.001086973	0.0407790423680014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.0407790423680014
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.03607320406343427
SOTOS SYNDROME 2	0.0009615380000000001	0.03607320406343427
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.03607320406343427
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.03607320406343427
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0009615380000000001	0.03607320406343427
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.03607320406343427
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.03607320406343427
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.03607320406343427
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.03607320406343427
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	0.03607320406343427
COG1-CDG	0.0009615380000000001	0.03607320406343427
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.03607320406343427
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.03607320406343427
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.03607320406343427
MENTAL RETARDATION, X-LINKED 93	0.0009615380000000001	0.03607320406343427
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	0.03607320406343427
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.03607320406343427
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	0.03607320406343427
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.03607320406343427
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.03607320406343427
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.03607320406343427
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.03607320406343427
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.03607320406343427
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0009615380000000001	0.03607320406343427
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.03607320406343427
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.03607320406343427
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.03607320406343427
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	0.03607320406343427
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.03607320406343427
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.03607320406343427
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.03607320406343427
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.03607320406343427
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.03607320406343427
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.03607320406343427
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.03607320406343427
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.03607320406343427
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.03607320406343427
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	0.03607320406343427
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.03607320406343427
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.03607320406343427
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.03607320406343427
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.03607320406343427
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.03607320406343427
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.03607320406343427
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	0.03607320406343427
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.03607320406343427
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.03607320406343427
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.03607320406343427
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.03607320406343427
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.03607320406343427
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.03607320406343427
ETHANOLAMINOSIS	0.0009615380000000001	0.03607320406343427
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.03607320406343427
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.03607320406343427
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	0.03607320406343427
CAP MYOPATHY	0.0009615380000000001	0.03607320406343427
CHITAYAT SYNDROME	0.0009615380000000001	0.03607320406343427
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	0.03607320406343427
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0009615380000000001	0.03607320406343427
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.03607320406343427
SENGERS SYNDROME	0.0009615380000000001	0.03607320406343427
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0009615380000000001	0.03607320406343427
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.03607320406343427
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0009615380000000001	0.03607320406343427
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	0.03607320406343427
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.03607320406343427
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.03607320406343427
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.03607320406343427
RING CHROMOSOME 13 SYNDROME	0.0009615380000000001	0.03607320406343427
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.03607320406343427
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.03607320406343427
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.03607320406343427
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.03607320406343427
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0009615380000000001	0.03607320406343427
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.03607320406343427
PRIMROSE SYNDROME; PRIMS	0.0009615380000000001	0.03607320406343427
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0009615380000000001	0.03607320406343427
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.03607320406343427
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.03607320406343427
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.03607320406343427
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.03607320406343427
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.03607320406343427
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.03607320406343427
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.03607320406343427
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.03607320406343427
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.03607320406343427
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.03607320406343427
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.03607320406343427
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.03607320406343427
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.03607320406343427
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.03607320406343427
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.03607320406343427
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0009615380000000001	0.03607320406343427
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.03607320406343427
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.03607320406343427
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.03607320406343427
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.03607320406343427
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.03607320406343427
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	0.03607320406343427
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.03607320406343427
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.03607320406343427
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.03607320406343427
LEGIUS SYNDROME	0.0009615380000000001	0.03607320406343427
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.03607320406343427
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.03607320406343427
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.03607320406343427
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.03607320406343427
NEMALINE MYOPATHY 4	0.0009615380000000001	0.03607320406343427
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.03607320406343427
PIERSON SYNDROME	0.0009615380000000001	0.03607320406343427
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.03607320406343427
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.03607320406343427
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.03607320406343427
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.03607320406343427
WARBURG MICRO SYNDROME 1	0.0009615380000000001	0.03607320406343427
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.03607320406343427
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.03607320406343427
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.03607320406343427
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	0.03607320406343427
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0009615380000000001	0.03607320406343427
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.03607320406343427
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.03607320406343427
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.03607320406343427
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.03607320406343427
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	0.03607320406343427
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.03607320406343427
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.03607320406343427
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.03607320406343427
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343427
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.03607320406343427
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.03607320406343427
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.03607320406343427
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.03607320406343427
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.03607320406343427
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.03607320406343427
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608926
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608926
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608926
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608926
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608926
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608926
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608926
HURLER SYNDROME	0.000545554	0.020467085824608926
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608926
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608926
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608926
OXOGLUTARIC ACIDURIA	0.000545554	0.020467085824608926
JAWAD SYNDROME	0.000545554	0.020467085824608926
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020467085824608926
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608926
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608926
TRANSALDOLASE DEFICIENCY	0.000545554	0.020467085824608926
MEDULLOBLASTOMA	0.000545554	0.020467085824608926
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608926
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608926
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608926
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608926
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608926
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608926
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608926
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020467085824608926
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608926
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020467085824608926
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608926
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608926
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608926
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608926
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608926
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608926
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608926
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608926
OROTIC ACIDURIA	0.000545554	0.020467085824608926
FRIAS SYNDROME	0.000545554	0.020467085824608926
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608926
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608926
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608926
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608926
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608926
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608926
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608926
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020467085824608926
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608926
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608926
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608926
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020467085824608926
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608926
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608926
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608926
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608926
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020467085824608926
FARBER DISEASE	0.000545554	0.020467085824608926
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608926
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608926
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020467085824608926
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608926
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020467085824608926
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608926
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608926
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608926
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608926
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608926
ALG6-CDG	0.000545554	0.020467085824608926
MEIER-GORLIN SYNDROME 7	0.000545554	0.020467085824608926
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608926
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020467085824608926
LIG4 SYNDROME	0.000545554	0.020467085824608926
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608926
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608926
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608926
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608926
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608926
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608926
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608926
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608926
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608926
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
DEXTROCARDIA	0.000545554	0.020467085824608926
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608926
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608926
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608926
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020467085824608926
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608926
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608926
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608926
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608926
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608926
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
CDAGS SYNDROME	0.000545554	0.020467085824608926
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608926
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608926
SYNDROMIC DIARRHEA	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608926
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608926
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608926
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020467085824608926
WOLMAN DISEASE	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608926
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608926
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608926
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608926
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608926
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608926
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608926
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608926
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608926
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608926
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608926
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608926
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608926
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020467085824608926
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608926
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608926
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608926
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608926
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608926
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608926
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020467085824608926
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608926
CHAR SYNDROME	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608926
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608926
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608926
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608926
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608926
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608926
N SYNDROME	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608926
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608926
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020467085824608926
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608926
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020467085824608926
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608926
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608926
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020467085824608926
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608926
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608926
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608926
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608926
BARATELA-SCOTT SYNDROME	0.000545554	0.020467085824608926
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608926
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608926
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608926
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608926
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608926
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608926
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608926
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020467085824608926
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608926
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608926
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608926
HOLOPROSENCEPHALY 11	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608926
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608926
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608926
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020467085824608926
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608926
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608926
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020467085824608926
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608926
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608926
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608926
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608926
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608926
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608926
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608926
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608926
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608926
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020467085824608926
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020467085824608926
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020467085824608926
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608926
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608926
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.020467085824608926
CODAS SYNDROME	0.000545554	0.020467085824608926
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608926
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608926
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020467085824608926
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608926
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608926
TETRASOMY X	0.000545554	0.020467085824608926
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020467085824608926
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020467085824608926
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608926
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608926
REVESZ SYNDROME	0.000545554	0.020467085824608926
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608926
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608926
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020467085824608926
RAHMAN SYNDROME	0.000545554	0.020467085824608926
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608926
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.020467085824608926
12Q14 MICRODELETION SYNDROME	0.000545554	0.020467085824608926
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608926
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608926
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020467085824608926
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608926
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608926
MONOSOMY 13Q34	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608926
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608926
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020467085824608926
STEEL SYNDROME; STLS	0.000545554	0.020467085824608926
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020467085824608926
3MC SYNDROME 2	0.000545554	0.020467085824608926
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608926
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608926
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608926
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608926
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608926
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020467085824608926
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.020467085824608926
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608926
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608926
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020467085824608926
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608926
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608926
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608926
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608926
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608926
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608926
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608926
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608926
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608926
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608926
CURRARINO SYNDROME	0.000545554	0.020467085824608926
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608926
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608926
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608926
RIDDLE SYNDROME	0.000545554	0.020467085824608926
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020467085824608926
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608926
LIG4 SYNDROME	0.000545554	0.020467085824608926
MONOSOMY 18P	0.000545554	0.020467085824608926
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608926
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608926
TRIPLE A SYNDROME	0.000541419	0.02031195654339248
NIPAH VIRUS DISEASE	0.000541419	0.02031195654339248
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02031195654339248
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.02031195654339248
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.02031195654339248
SANDHOFF DISEASE	0.000541419	0.02031195654339248
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02031195654339248
XERODERMA PIGMENTOSUM	0.000541419	0.02031195654339248
PARIETAL FORAMINA	0.000541419	0.02031195654339248
DYSOSTEOSCLEROSIS	0.000541419	0.02031195654339248
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02031195654339248
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02031195654339248
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02031195654339248
DERMOTRICHIC SYNDROME	0.000541419	0.02031195654339248
PAPILLORENAL SYNDROME	0.000541419	0.02031195654339248
DARIER-WHITE DISEASE; DAR	0.000541419	0.02031195654339248
FOUNTAIN SYNDROME	0.000541419	0.02031195654339248
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.02031195654339248
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02031195654339248
LASSA FEVER	0.000541419	0.02031195654339248
CROUZON SYNDROME	0.000541419	0.02031195654339248
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02031195654339248
EPILEPSY-TELANGIECTASIA	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02031195654339248
BANGSTAD SYNDROME	0.000541419	0.02031195654339248
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02031195654339248
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.02031195654339248
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02031195654339248
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02031195654339248
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02031195654339248
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02031195654339248
ALEXANDER DISEASE	0.000541419	0.02031195654339248
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.02031195654339248
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02031195654339248
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02031195654339248
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02031195654339248
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02031195654339248
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02031195654339248
FETAL GAUCHER DISEASE	0.000541419	0.02031195654339248
HUNTINGTON DISEASE; HD	0.000541419	0.02031195654339248
2Q33.1 DELETION SYNDROME	0.000541419	0.02031195654339248
SYSTEMIC SCLEROSIS	0.000541419	0.02031195654339248
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02031195654339248
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02031195654339248
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02031195654339248
MEHMO SYNDROME	0.000541419	0.02031195654339248
AUTISM	0.000541419	0.02031195654339248
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.02031195654339248
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.02031195654339248
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02031195654339248
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.02031195654339248
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02031195654339248
DIAMINOPENTANURIA	0.000541419	0.02031195654339248
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02031195654339248
STURGE-WEBER SYNDROME	0.000541419	0.02031195654339248
ISOLATED SPINA BIFIDA	0.000541419	0.02031195654339248
ADRENOMYODYSTROPHY	0.000541419	0.02031195654339248
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02031195654339248
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.02031195654339248
SCRUB TYPHUS	0.000541419	0.02031195654339248
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.02031195654339248
1P36 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02031195654339248
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02031195654339248
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02031195654339248
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339248
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02031195654339248
INSULINOMA	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02031195654339248
ENCEPHALITIS LETHARGICA	0.000541419	0.02031195654339248
CROME SYNDROME	0.000541419	0.02031195654339248
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02031195654339248
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02031195654339248
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02031195654339248
EPILEPSY, READING	0.000541419	0.02031195654339248
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02031195654339248
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02031195654339248
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02031195654339248
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02031195654339248
EPENDYMOMA	0.000541419	0.02031195654339248
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02031195654339248
JUVENILE HUNTINGTON DISEASE	0.000541419	0.02031195654339248
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.02031195654339248
SECKEL SYNDROME 7; SCKL7	0.000541419	0.02031195654339248
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02031195654339248
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02031195654339248
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.02031195654339248
SUBEPENDYMOMA	0.000541419	0.02031195654339248
MOYAMOYA DISEASE	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.02031195654339248
PINEOBLASTOMA	0.000541419	0.02031195654339248
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.02031195654339248
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02031195654339248
MICROSPORIDIOSIS	0.000541419	0.02031195654339248
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02031195654339248
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02031195654339248
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02031195654339248
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02031195654339248
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02031195654339248
CONGENITAL HYDROCEPHALUS	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02031195654339248
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02031195654339248
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02031195654339248
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02031195654339248
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02031195654339248
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.02031195654339248
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02031195654339248
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02031195654339248
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.02031195654339248
SANJAD-SAKATI SYNDROME	0.000541419	0.02031195654339248
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02031195654339248
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.02031195654339248
MOMO SYNDROME	0.000541419	0.02031195654339248
MOYNAHAN SYNDROME	0.000541419	0.02031195654339248
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02031195654339248
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02031195654339248
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02031195654339248
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.02031195654339248
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02031195654339248
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.02031195654339248
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02031195654339248
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02031195654339248
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02031195654339248
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02031195654339248
PORENCEPHALY	0.000541419	0.02031195654339248
PROLACTINOMA	0.000541419	0.02031195654339248
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02031195654339248
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02031195654339248
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.02031195654339248
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02031195654339248
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339248
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02031195654339248
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02031195654339248
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02031195654339248
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02031195654339248
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02031195654339248
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02031195654339248
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02031195654339248
PERRAULT SYNDROME 3	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02031195654339248
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.02031195654339248
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02031195654339248
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02031195654339248
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02031195654339248
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02031195654339248
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.02031195654339248
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02031195654339248
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.02031195654339248
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02031195654339248
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.02031195654339248
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02031195654339248
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02031195654339248
KNOBLOCH SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02031195654339248
COFS SYNDROME	0.000541419	0.02031195654339248
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02031195654339248
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02031195654339248
CRISPONI SYNDROME	0.000541419	0.02031195654339248
CRYPTOCOCCOSIS	0.000541419	0.02031195654339248
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02031195654339248
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02031195654339248
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02031195654339248
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02031195654339248
BOWEN-CONRADI SYNDROME	0.000541419	0.02031195654339248
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02031195654339248
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02031195654339248
ROMANO-WARD SYNDROME	0.000541419	0.02031195654339248
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02031195654339248
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02031195654339248
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02031195654339248
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.02031195654339248
BEHÇET DISEASE	0.000541419	0.02031195654339248
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.02031195654339248
BETA-MANNOSIDOSIS	0.000541419	0.02031195654339248
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02031195654339248
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02031195654339248
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02031195654339248
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.02031195654339248
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02031195654339248
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02031195654339248
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.02031195654339248
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02031195654339248
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02031195654339248
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02031195654339248
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02031195654339248
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02031195654339248
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02031195654339248
EPISODIC ATAXIA TYPE 6	0.000541419	0.02031195654339248
HARROD SYNDROME	0.000541419	0.02031195654339248
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02031195654339248
CYSTATHIONINURIA	0.000541419	0.02031195654339248
HENNEKAM-BEEMER SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02031195654339248
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02031195654339248
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02031195654339248
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02031195654339248
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02031195654339248
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.02031195654339248
FRONTAL ENCEPHALOCELE	0.000541419	0.02031195654339248
2Q24 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02031195654339248
WOLCOTT-RALLISON SYNDROME	0.000541419	0.02031195654339248
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
DISTAL TRISOMY 15Q	0.000541419	0.02031195654339248
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02031195654339248
DYSEQUILIBRIUM SYNDROME	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02031195654339248
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02031195654339248
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.02031195654339248
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.02031195654339248
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.02031195654339248
COCKAYNE SYNDROME	0.000541419	0.02031195654339248
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.02031195654339248
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02031195654339248
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02031195654339248
BERNARD-SOULIER SYNDROME	0.000541419	0.02031195654339248
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS	0.000541419	0.02031195654339248
MILLER-DIEKER SYNDROME	0.000541419	0.02031195654339248
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.02031195654339248
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02031195654339248
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02031195654339248
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02031195654339248
CENTRONUCLEAR MYOPATHY	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02031195654339248
ONDINE SYNDROME	0.000541419	0.02031195654339248
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02031195654339248
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02031195654339248
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02031195654339248
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02031195654339248
NORRIE DISEASE	0.000541419	0.02031195654339248
LHERMITTE-DUCLOS DISEASE	0.000541419	0.02031195654339248
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02031195654339248
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02031195654339248
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02031195654339248
ATKIN-FLAITZ SYNDROME	0.000541419	0.02031195654339248
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02031195654339248
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02031195654339248
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02031195654339248
THREONINEMIA	0.000541419	0.02031195654339248
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02031195654339248
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02031195654339248
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02031195654339248
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
LEIGH SYNDROME	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02031195654339248
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02031195654339248
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02031195654339248
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02031195654339248
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02031195654339248
HYPERLYSINEMIA, TYPE I	0.000541419	0.02031195654339248
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02031195654339248
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02031195654339248
HYPER-BETA-ALANINEMIA	0.000541419	0.02031195654339248
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
DEND SYNDROME	0.000541419	0.02031195654339248
EPISODIC ATAXIA TYPE 3	0.000541419	0.02031195654339248
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02031195654339248
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02031195654339248
DPM1-CDG	0.000541419	0.02031195654339248
MPDU1-CDG	0.000541419	0.02031195654339248
ALG2-CDG	0.000541419	0.02031195654339248
ALG9-CDG	0.000541419	0.02031195654339248
MOGS-CDG	0.000541419	0.02031195654339248
HYPERPROLINEMIA, TYPE II	0.000541419	0.02031195654339248
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02031195654339248
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02031195654339248
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.02031195654339248
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02031195654339248
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.02031195654339248
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02031195654339248
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02031195654339248
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02031195654339248
KRABBE DISEASE	0.000541419	0.02031195654339248
KIFAFA SEIZURE DISORDER	0.000541419	0.02031195654339248
KEUTEL SYNDROME; KTLS	0.000541419	0.02031195654339248
PRADER-WILLI SYNDROME	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02031195654339248
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02031195654339248
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02031195654339248
RABIES	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02031195654339248
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02031195654339248
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS 2	0.000541419	0.02031195654339248
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.02031195654339248
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02031195654339248
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02031195654339248
MERCURY POISONING	0.000541419	0.02031195654339248
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02031195654339248
TETRASOMY 18P	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02031195654339248
THYROCEREBRORENAL SYNDROME	0.000541419	0.02031195654339248
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02031195654339248
VIRAL HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02031195654339248
WHIPPLE DISEASE	0.000541419	0.02031195654339248
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02031195654339248
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02031195654339248
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.02031195654339248
GALACTOSIALIDOSIS	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02031195654339248
RENPENNING SYNDROME	0.000541419	0.02031195654339248
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02031195654339248
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02031195654339248
ISOLATED BILIARY ATRESIA	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02031195654339248
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02031195654339248
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.02031195654339248
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02031195654339248
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02031195654339248
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
15Q OVERGROWTH SYNDROME	0.000541419	0.02031195654339248
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02031195654339248
LUJO HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02031195654339248
RIFT VALLEY FEVER	0.000541419	0.02031195654339248
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02031195654339248
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02031195654339248
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02031195654339248
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02031195654339248
HYPERPROLINEMIA TYPE 1	0.000541419	0.02031195654339248
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 47	0.000541419	0.02031195654339248
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02031195654339248
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.02031195654339248
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02031195654339248
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
CLARK-BARAITSER SYNDROME	0.000541419	0.02031195654339248
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02031195654339248
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02031195654339248
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02031195654339248
RENPENNING SYNDROME 1; RENS1	0.000541419	0.02031195654339248
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02031195654339248
GLIOBLASTOMA	0.000541419	0.02031195654339248
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02031195654339248
GURRIERI SYNDROME	0.000541419	0.02031195654339248
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02031195654339248
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02031195654339248
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02031195654339248
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02031195654339248
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02031195654339248
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.02031195654339248
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02031195654339248
CLASSIC HOMOCYSTINURIA	0.000541419	0.02031195654339248
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02031195654339248
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02031195654339248
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02031195654339248
